image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k | table_fragment_1 stringlengths 43 8.42k | table_fragment_2 stringlengths 39 8.21k |
|---|---|---|---|---|
7ce7ae4666e8e6c7bcda4a7f74f14fa2e46a9df93821f425be4d2a807db63de2.png | simple | <table><tr><td>Attribute</td><td>Value</td><td>% of total<sup>a</sup></td></tr><tr><td>Genome size (bp)</td><td>4,071,168</td><td>100</td></tr><tr><td>DNA cding region (bp)</td><td>3,565,936</td><td>87.5</td></tr><tr><td>DNA G+C content (bp)</td><td>1,880,879</td><td>46.1</td></tr><tr><td>Total number of genes<sup>b</s... | <table><tr><td>Attribute</td></tr><tr><td>Genome size (bp)</td></tr><tr><td>DNA cding region (bp)</td></tr><tr><td>DNA G+C content (bp)</td></tr><tr><td>Total number of genesb</td></tr><tr><td>RNA genes</td></tr><tr><td>rRNA operons</td></tr><tr><td>Protein-coding genes</td></tr><tr><td>CDSs with predicted functions</t... | <table><tr><td>Value</td><td>% of totala</td></tr><tr><td>4,071,168</td><td>100</td></tr><tr><td>3,565,936</td><td>87.5</td></tr><tr><td>1,880,879</td><td>46.1</td></tr><tr><td>4095</td><td>n/a</td></tr><tr><td>116</td><td>n/a</td></tr><tr><td>10</td><td>n/a</td></tr><tr><td>3912</td><td>100</td></tr><tr><td>3170</td><... |
739191dd48cc02b95518a97a7bdc1b1cf2628c715cee8b28d0391b626f62839f.png | simple | <table><tr><td>Parameters<sup>a</sup></td><td>ND</td><td>HFD</td><td>HFD + ACG</td><td>HFD + QHD</td><td>HFD + RGZ</td></tr><tr><td>Body weight (g)</td><td>29.69 ± 2.89</td><td>45.85 ± 2.23<sup>##</sup></td><td>34.69 ± 2.84<sup><i>∗∗</i></sup></td><td>32.75 ± 2.66<sup><i>∗∗</... | <table><tr><td>Parametersa</td><td>ND</td><td>HFD</td><td>HFD + ACG</td><td>HFD + QHD</td><td>HFD + RGZ</td></tr><tr><td>Body weight (g)</td><td>29.69 ± 2.89</td><td>45.85 ± 2.23##</td><td>34.69 ± 2.84∗∗</td><td>32.75 ± 2.66∗∗</td><td>33.54 ± 2.57∗∗</td></tr><tr><td>Food intake (g/day)</td><td>2.60 ± 0.09</td><td>2.77 ... | <table><tr><td>Parametersa</td><td>ND</td><td>HFD</td><td>HFD + ACG</td><td>HFD + QHD</td><td>HFD + RGZ</td></tr><tr><td>Liver weight (g)</td><td>1.06 ± 0.10</td><td>2.45 ± 0.14##</td><td>1.35 ± 0.38∗∗&</td><td>1.56 ± 0.45∗∗</td><td>1.67 ± 0.43∗∗</td></tr><tr><td>Liver/body weight ratio</td><td>3.60 ± 0.37</td><td>5.36... |
e868575bfaebaeb67b67f7c5e7c96924a1efea4ef27aaf1a24bd4ce9646511b3.png | simple | <table><tr><td></td><td>I</td><td></td><td>II</td><td></td><td>III</td><td></td><td>IV</td><td></td><td>V</td><td></td><td>X</td><td></td></tr><tr><td></td><td>4856</td><td>4858</td><td>4856</td><td>4858</td><td>4856</td><td>4858</td><td>4856</td><td>4858</td><td>4856</td><td>4858</td><td>4856</td><td>4858</td></tr><tr... | <table><tr><td></td><td>I</td><td></td><td>II</td><td></td></tr><tr><td></td><td>4856</td><td>4858</td><td>4856</td><td>4858</td></tr><tr><td>Function</td><td></td><td></td><td></td><td></td></tr><tr><td>Exon</td><td></td><td></td><td></td><td></td></tr><tr><td>Insert</td><td>9,942</td><td>91</td><td>16,423</td><td>334... | <table><tr><td>III</td><td></td><td>IV</td><td></td><td>V</td><td></td><td>X</td><td></td></tr><tr><td>4856</td><td>4858</td><td>4856</td><td>4858</td><td>4856</td><td>4858</td><td>4856</td><td>4858</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td>... |
0bdd06b531ff18062c66a72cc5b42ef236524954c90d35d8bfd00fc6002f46c1.png | simple | <table><tr><td>Suboptimal factors N (%)</td><td>All patients</td><td>ethnic Dutch</td><td>Surinamese/Antillean</td><td>'Other non-western'</td></tr><tr><td>Education & Counselling</td><td>11 (22.45)</td><td>5 (33.33)</td><td>3 (20.00)</td><td>3 (15,79)</td></tr><tr><td>Prescriptions & types of inhalation device... | <table><tr><td>Suboptimal factors N (%)</td><td>All patients</td><td>ethnic Dutch</td><td>Surinamese/Antillean</td></tr><tr><td>Education & Counselling</td><td>11 (22.45)</td><td>5 (33.33)</td><td>3 (20.00)</td></tr><tr><td>Prescriptions & types of inhalation devices</td><td>13 (26.53)</td><td>4 (26.67)</td><td>2 (13.3... | <table><tr><td>'Other non-western'</td></tr><tr><td>3 (15,79)</td></tr><tr><td>7 (36,84)</td></tr><tr><td>2 (10,53)</td></tr><tr><td>3 (15,79)</td></tr><tr><td>2 (10,53)</td></tr><tr><td>2 (10,53)</td></tr><tr><td>19 (38,78)</td></tr></table> |
b15711c1e4287b2063945ae1471a21a6d92e2971a1b12e4684109680d771d3fa.png | simple | <table><tr><td>Point</td><td>Stress shielding rate in the traditional prosthesis group (<i>η</i>%)</td><td>Stress shielding rate in the anatomic prosthesis group (<i>η</i>%)</td></tr><tr><td>1</td><td> </td><td>18.6 (1.6)</td></tr><tr><td>2</td><td> </td><td>21.2 (2.1)</td></tr><tr><td>3</td><td> </td><td>24.... | <table><tr><td>Point</td><td>Stress shielding rate in the traditional prosthesis group (η%)</td><td>Stress shielding rate in the anatomic prosthesis group (η%)</td></tr><tr><td>1</td><td></td><td>18.6 (1.6)</td></tr><tr><td>2</td><td></td><td>21.2 (2.1)</td></tr><tr><td>3</td><td></td><td>24.9 (1.9)</td></tr><tr><td>4<... | <table><tr><td>15</td><td>25.0 (1.6)</td><td>18.5 (1.2)</td></tr><tr><td>16</td><td>1.5 (0.2)</td><td>1.41 (0.1)</td></tr><tr><td>17</td><td>17.9 (1.9)</td><td>10.3 (0.8)</td></tr><tr><td>18</td><td>12.6 (1.1)</td><td>4.3 (0.3)</td></tr></table> |
a36a329675404415aa61f4e26ff336cee03331a831db7b65d676135a04e0daf2.png | complex | <table><tr><td> </td><td colspan="2"><i>Exercise</i></td><td colspan="2"><i>Control</i></td><td><i>P</i></td><td><i>η</i><sub><i>p</i></sub><sup><i>2</i></sup></td></tr><tr><td> </td><td><i>Baseline</i></td><td><i>PI</i></td><td><i>Baseline</i></td><td><i>PI</i></td><td> </td><td> </td></tr><tr><td colspan="7"><i>... | <table><tr><td></td><td colspan="2">Exercise</td><td colspan="2">Control</td><td>P</td><td>ηp2</td></tr><tr><td></td><td>Baseline</td><td>PI</td><td>Baseline</td><td>PI</td><td></td><td></td></tr><tr><td colspan="7">MAP (mm Hg)</td></tr><tr><td>X</td><td>96</td><td>90</td><td>98</td><td>96</td><td>0.160</td><td>0.05</t... | <table><tr><td></td><td colspan="2">Exercise</td><td colspan="2">Control</td><td>P</td><td>ηp2</td></tr><tr><td></td><td>Baseline</td><td>PI</td><td>Baseline</td><td>PI</td><td></td><td></td></tr><tr><td colspan="7">cPP (mm Hg)</td></tr><tr><td>X</td><td>49</td><td>43</td><td>53</td><td>55</td><td>0.011a</td><td>0.14</... |
725787880f2d2d1586bee13a7ed68554d95022f8e9d1ce42a7d46535f5977045.png | complex | <table><tr><td></td><td colspan="2">All characters</td><td colspan="2">Forrest-only</td><td colspan="2">Jenny-only</td></tr><tr><td></td><td>Audio-visual</td><td>Audio-only</td><td>Audio-visual</td><td>Audio-only</td><td>Audio-visual</td><td>Audio-only</td></tr><tr><td><i>Dimensional emotion attributes</i>ArousalValenc... | <table><tr><td></td><td colspan="2">All characters</td><td colspan="2">Forrest-only</td><td colspan="2">Jenny-only</td></tr><tr><td></td><td>Audio-visual</td><td>Audio-only</td><td>Audio-visual</td><td>Audio-only</td><td>Audio-visual</td><td>Audio-only</td></tr><tr><td>Dimensional emotion attributesArousalValenceDirect... | <table><tr><td>Emotion onset cuesAudioContextFaceGestureNarratorVerbal</td><td>0.418 ±0.0080.384 ±0.0100.713 ±0.0060.619 ±0.010n/a0.637 ±0.008</td><td>0.037 ±0.051n/an/an/a0.251 ±0.0470.368 ±0.107</td><td>0.354 ±0.0130.424 ±0.0110.687 ±0.0100.532 ±0.011n/a0.565 ±0.007</td><td>n/an/an/an/a0.202 ±0.0450.455 ±0.042</td><t... |
3828e84190c0abb7d2651262721e7c31dbbdc959328c83ca7dd6b8dd82a5626d.png | complex | <table><tr><td rowspan="2">Domain</td><td colspan="2">SED PAQ</td><td colspan="2">SED ACC</td><td colspan="2">LPA PAQ</td><td colspan="2">LPA ACC</td><td colspan="2">MVPA PAQ</td><td colspan="2">MVPA ACC</td></tr><tr><td>Mean (SD)</td><td>% (Day)</td><td>Mean (SD)</td><td>% (Day)</td><td>Mean (SD)</td><td>% (Day)</td><... | <table><tr><td rowspan="2">Domain</td><td colspan="2">SED PAQ</td><td colspan="2">SED ACC</td><td colspan="2">LPA PAQ</td><td colspan="2">LPA ACC</td><td colspan="2">MVPA PAQ</td><td colspan="2">MVPA ACC</td></tr><tr><td>Mean (SD)</td><td>% (Day)</td><td>Mean (SD)</td><td>% (Day)</td><td>Mean (SD)</td><td>% (Day)</td><... | <table><tr><td rowspan="2">Domain</td><td colspan="2">SED PAQ</td><td colspan="2">SED ACC</td><td colspan="2">LPA PAQ</td><td colspan="2">LPA ACC</td><td colspan="2">MVPA PAQ</td><td colspan="2">MVPA ACC</td></tr><tr><td>Mean (SD)</td><td>% (Day)</td><td>Mean (SD)</td><td>% (Day)</td><td>Mean (SD)</td><td>% (Day)</td><... |
4468588315320bb13e70db0f7f2998b72804b26ddc7b81d0fb10f3c24f382abf.png | simple | <table><tr><td></td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td><td>7</td><td>8</td><td>9</td><td>10</td></tr><tr><td>1. Playfulness</td><td>–</td><td>013</td><td>−001</td><td>406<sup>**</sup></td><td>396<sup>**</sup></td><td>−295<sup>**</sup></td><td>289<sup>**</sup></td><td>308<sup>*... | <table><tr><td></td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td></tr><tr><td>1. Playfulness</td><td>–</td><td>013</td><td>−001</td><td>406**</td><td>396**</td><td>−295**</td></tr><tr><td>2. Disruptive (SR)</td><td>009</td><td>–</td><td>298**</td><td>−299**</td><td>256*</td><td>−317**</td></tr><tr><td>3.... | <table><tr><td>7</td><td>8</td><td>9</td><td>10</td></tr><tr><td>289**</td><td>308**</td><td>361**</td><td>402**</td></tr><tr><td>043</td><td>041</td><td>019</td><td>283**</td></tr><tr><td>−307**</td><td>046</td><td>155*</td><td>362**</td></tr><tr><td>−328**</td><td>−015</td><td>313**</td><td>340**</td></tr><tr><td>288... |
2e75b7f9eb844325b24db8310eaed6890b0890d2966218a25aea682489442067.png | simple | <table><tr><td>Position</td><td>δ<sub>H</sub> mult (<i>J</i> Hz)</td><td>δ<sub>C</sub> mult</td><td>HMBC</td></tr><tr><td>1</td><td></td><td>195.5, C</td><td>2</td></tr><tr><td>2</td><td>3.70, d (2.4)</td><td>68.4, CH</td><td></td></tr><tr><td>3</td><td>3.86, ddd (7.2, 1.9, 1.9)</td><td>72.5, CH</td><td>2, 4,... | <table><tr><td>Position</td><td>δH mult (J Hz)</td><td>δC mult</td><td>HMBC</td></tr><tr><td>1</td><td></td><td>195.5, C</td><td>2</td></tr><tr><td>2</td><td>3.70, d (2.4)</td><td>68.4, CH</td><td></td></tr><tr><td>3</td><td>3.86, ddd (7.2, 1.9, 1.9)</td><td>72.5, CH</td><td>2, 4, 5</td></tr><tr><td>4</td><td>1.51, m; ... | <table><tr><td>Position</td><td>δH mult (J Hz)</td><td>δC mult</td><td>HMBC</td></tr><tr><td>31</td><td>0.87, t (7.1)</td><td>13.7, CH3</td><td>30</td></tr></table> |
1e50e3634f1717737d57da92876fbd5bc1e1669d557fc0a565b3463a28610f36.png | complex | <table><tr><td rowspan="2">Data Type</td><td colspan="2">Control</td><td colspan="2">Cold</td><td colspan="2">Freezing</td></tr><tr><td>Total Reads</td><td>Unique Reads</td><td>Total Reads</td><td>Unique Reads</td><td>Total Reads</td><td>Unique Reads</td></tr><tr><td>Clean reads</td><td>10,823,011</td><td>4,415,425</td... | <table><tr><td rowspan="2">Data Type</td><td colspan="2">Control</td><td colspan="2">Cold</td><td colspan="2">Freezing</td></tr><tr><td>Total Reads</td><td>Unique Reads</td><td>Total Reads</td><td>Unique Reads</td><td>Total Reads</td><td>Unique Reads</td></tr><tr><td>Clean reads</td><td>10,823,011</td><td>4,415,425</td... | <table><tr><td rowspan="2">Data Type</td><td colspan="2">Control</td><td colspan="2">Cold</td><td colspan="2">Freezing</td></tr><tr><td>Total Reads</td><td>Unique Reads</td><td>Total Reads</td><td>Unique Reads</td><td>Total Reads</td><td>Unique Reads</td></tr><tr><td>Known miRNA</td><td>1,597,215</td><td>24,334</td><td... |
05e719ed36874b04eda8c380c617e55bba163d1dd87d9b449dcc295b727ca7a4.png | complex | <table><tr><td rowspan="2">Treatment phase</td><td rowspan="2">Parameter</td><td colspan="4">Experts</td><td>Faesibility study [28]</td></tr><tr><td>Unit</td><td>Median</td><td>Min</td><td>Max</td><td>Median</td></tr><tr><td rowspan="4">Positioning</td><td>Time patient verification</td><td>min</td><td>15</td><td>10</td... | <table><tr><td rowspan="2">Treatment phase</td><td rowspan="2">Parameter</td><td colspan="4">Experts</td><td>Faesibility study [28]</td></tr><tr><td>Unit</td><td>Median</td><td>Min</td><td>Max</td><td>Median</td></tr><tr><td rowspan="4">Positioning</td><td>Time patient verification</td><td>min</td><td>15</td><td>10</td... | <table><tr><td rowspan="2">Treatment phase</td><td rowspan="2">Parameter</td><td colspan="4">Experts</td><td>Faesibility study [28]</td></tr><tr><td>Unit</td><td>Median</td><td>Min</td><td>Max</td><td>Median</td></tr><tr><td>Test</td><td>Chance of adjustment focal point per coronal plane</td><td>-</td><td>0.55</td><td>... |
6954905c23fa48719a8712342694aa1d4daad49800810abe3ee1973c082be1bc.png | simple | <table><tr><td>Symbol</td><td>Definition</td><td>Theory</td><td>Experiment</td></tr><tr><td>PRR</td><td>Packet Reception Rate</td><td>Varying</td><td>Varying</td></tr><tr><td>BER</td><td>Bit Error Rate</td><td>Varying</td><td>Varying</td></tr><tr><td>SNR</td><td>Signal to Noise Ratio</td><td>Varying</td><td>Varying</td... | <table><tr><td>Symbol</td><td>Definition</td></tr><tr><td>PRR</td><td>Packet Reception Rate</td></tr><tr><td>BER</td><td>Bit Error Rate</td></tr><tr><td>SNR</td><td>Signal to Noise Ratio</td></tr><tr><td>RSSI</td><td>Receiver Signal Strength Indicator</td></tr><tr><td>fdata</td><td>Date frame size in bits</td></tr><tr>... | <table><tr><td>Theory</td><td>Experiment</td></tr><tr><td>Varying</td><td>Varying</td></tr><tr><td>Varying</td><td>Varying</td></tr><tr><td>Varying</td><td>Varying</td></tr><tr><td>Varying</td><td>Varying</td></tr><tr><td>272</td><td>272</td></tr><tr><td>64</td><td>64</td></tr><tr><td>Varying</td><td>Varying</td></tr><... |
b06c84e2c2eda60047ec3070e9504dd6b8e41e2f3262177c172361cc18284fa3.png | simple | <table><tr><td>Prognostic-risk group</td><td>Cytogenetic profile alone</td><td>Cytogenetic profile and molecular abnormalities</td></tr><tr><td>Favorable</td><td>t(8:21)(q22; q22)inv(16)(p13; 1q22)t(15;17)(q22; q12)</td><td>t(8:21)(q22; q22) with no c-KIT mutationinv(16)(p13; 1q22)t(15;17)(q22; q12)Mutated NPM1 without... | <table><tr><td>Prognostic-risk group</td><td>Cytogenetic profile alone</td></tr><tr><td>Favorable</td><td>t(8:21)(q22; q22)inv(16)(p13; 1q22)t(15;17)(q22; q12)</td></tr><tr><td>Intermediate</td><td>CN-AMLt(9;11)(p22; q23)Cytogenetic abnormalities not included in the favorable or adverse prognostic risk groups</td></tr>... | <table><tr><td>Cytogenetic profile and molecular abnormalities</td></tr><tr><td>t(8:21)(q22; q22) with no c-KIT mutationinv(16)(p13; 1q22)t(15;17)(q22; q12)Mutated NPM1 without FLT3-ITD (CN-AML)Mutated biallelic CEBPA (CN-AML)</td></tr><tr><td>t(8:21)(q22;q22) with mutated c-KITCN-AML other than those included in the f... |
a1b26cff313837b894060096afd2506bed4a5c194c2dbc93928dc8f8ab3e491f.png | complex | <table><tr><td rowspan="2">Age Groups (Years)</td><td rowspan="2">No. of Samples</td><td colspan="2">Specific activities of DBH (pmol/men/mg protein)a</td></tr><tr><td>Normal</td><td>Arsenicosis Patient</td></tr><tr><td>Group 1 (10-18)</td><td>9</td><td>376.4 ± 79.6</td><td>190.2 ± 57.0b</td></tr><tr><td>Grou... | <table><tr><td rowspan="2">Age Groups (Years)</td><td rowspan="2">No. of Samples</td><td colspan="2">Specific activities of DBH (pmol/men/mg protein)a</td></tr><tr><td>Normal</td><td>Arsenicosis Patient</td></tr></table> | <table><tr><td>Group 1 (10-18)</td><td>9</td><td>376.4 ± 79.6</td><td>190.2 ± 57.0b</td></tr><tr><td>Group 2 (20-40)</td><td>14</td><td>427.5 ± 60.2</td><td>348.8 ± 74.7c</td></tr><tr><td>Group 3 (45-70)</td><td>9</td><td>399.6 ± 86.7</td><td>415.7 ± 85.1d</td></tr></table> |
5ecef2e422dd5f615ee1061185ed149f10f168944a2cf227981c98a4cf8b1ea0.png | simple | <table><tr><td>Geographical regions and environmental variables</td><td>Malkangiri (Non-coastal)</td><td>Puri (Coastal)</td></tr><tr><td>Physical components</td><td></td><td></td></tr><tr><td>Temperature (Maximum, Minimum)</td><td>47 °C, 11 °C</td><td>36 °C, 13 °C</td></tr><tr><td>Average yearly rai... | <table><tr><td>Geographical regions and environmental variables</td><td>Malkangiri (Non-coastal)</td><td>Puri (Coastal)</td></tr><tr><td>Physical components</td><td></td><td></td></tr><tr><td>Temperature (Maximum, Minimum)</td><td>47 °C, 11 °C</td><td>36 °C, 13 °C</td></tr><tr><td>Average yearly rainfall in mm</td><td>... | <table><tr><td>Population Density per Sq. Km</td><td>106</td><td>488</td></tr><tr><td>Literacy Rate in percentage</td><td>49</td><td>85</td></tr></table> |
46fd0162476c4967aa532a3c73281eca9ae8068fa7000d1884efb906ba600b6c.png | complex | <table><tr><td>Independent variables</td><td>Total <i>N</i></td><td>Children with DH<i>N</i> (%)</td><td>PR (95% CI)</td><td><i>P</i><sup>*</sup></td></tr><tr><td>Age (cont.)</td><td> </td><td> </td><td>0.97(0.78 to 1.19)</td><td>0.784</td></tr><tr><td>Sex</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> (ref.... | <table><tr><td>Independent variables</td><td>Total N</td><td>Children with DHN (%)</td><td>PR (95% CI)</td><td>P*</td></tr><tr><td>Age (cont.)</td><td></td><td></td><td>0.97(0.78 to 1.19)</td><td>0.784</td></tr><tr><td>Sex</td><td></td><td></td><td></td><td></td></tr><tr><td>(ref.: male)</td><td>26</td><td>11 (42.3)</t... | <table><tr><td>Present</td><td>24</td><td>14 (58.3)</td><td>2.33(1.07 to 5.09)</td><td>0.033</td></tr><tr><td>Bitter taste</td><td></td><td></td><td></td><td></td></tr><tr><td>(ref.: no)</td><td>39</td><td>13 (33.3)</td><td>1.00</td><td rowspan="2">0.004</td></tr><tr><td>Yes</td><td>9</td><td>7 (77.8)</td><td>2.33(1.32... |
a05de6d867fe46dbe522781196b3b11307c4d83359d367439c4e9bdcf7b0eb86.png | simple | <table><tr><td>Variable</td><td>Number of TRBs (n = 43)</td><td>Odds ratio†</td><td>95% CI</td></tr><tr><td>Male</td><td>28</td><td>1.0</td><td>0.7-1.4</td></tr><tr><td>Age ≥65 years</td><td>6</td><td>5.3</td><td>3.7-7.6</td></tr><tr><td>Travel region‡</td><td>7</td><td>18.4</td><td>6.9-49.5</td></tr>... | <table><tr><td>Variable</td><td>Number of TRBs (n = 43)</td><td>Odds ratio†</td><td>95% CI</td></tr><tr><td>Male</td><td>28</td><td>1.0</td><td>0.7-1.4</td></tr></table> | <table><tr><td>Variable</td><td>Number of TRBs (n = 43)</td><td>Odds ratio†</td><td>95% CI</td></tr><tr><td>Age ≥65 years</td><td>6</td><td>5.3</td><td>3.7-7.6</td></tr><tr><td>Travel region‡</td><td>7</td><td>18.4</td><td>6.9-49.5</td></tr><tr><td>Sub-Saharan Africa</td><td>2</td><td>10.6</td><td>2.1-53.2</td></tr><tr... |
b858a9d6c96747a1861e544c96e2957e38eadfd5e64ca8639b4ad23fd4ac5566.png | complex | <table><tr><td rowspan="2">Species</td><td>Fructose</td><td>Mannitol</td><td>Sucrose</td><td>Trehalose</td><td>Total sugars </td></tr><tr><td colspan="5">(g/100 g fresh weight)</td></tr><tr><td><i>Agaricus bisporus </i></td><td>0.03</td><td>5.6</td><td>nd</td><td>0.16</td><td>5.79</td></tr><tr><td><i>Lentinus edodes </... | <table><tr><td>Species</td><td>Fructose</td><td>Mannitol</td><td>Sucrose</td><td>Trehalose</td><td>Total sugars</td></tr></table> | <table><tr><td>Species</td><td colspan="5">(g/100 g fresh weight)</td></tr><tr><td>Agaricus bisporus</td><td>0.03</td><td>5.6</td><td>nd</td><td>0.16</td><td>5.79</td></tr><tr><td>Lentinus edodes</td><td>0.69</td><td>10.01</td><td>nd</td><td>3.38</td><td>14.03</td></tr><tr><td>Pleurotus ostreatus</td><td>0.01</td><td>0... |
5f4c2fea735530c2b050d93bd73c9313473a38437ab877b5abe69156943541d8.png | simple | <table><tr><td>Antimicrobial agent</td><td>MIC</td></tr><tr><td>Cefazolin</td><td>> 16</td></tr><tr><td>Ampicillin/sulbactam</td><td>8</td></tr><tr><td>Ceftriaxone</td><td>≦ 0.5</td></tr><tr><td>Cefepime</td><td>≦ 0.5</td></tr><tr><td>Gentamicin</td><td>≦ 1</td></tr><tr><td>Levofloxacin</td><td>... | <table><tr><td>Antimicrobial agent</td><td>MIC</td></tr><tr><td>Cefazolin</td><td>> 16</td></tr><tr><td>Ampicillin/sulbactam</td><td>8</td></tr><tr><td>Ceftriaxone</td><td>≦ 0.5</td></tr><tr><td>Cefepime</td><td>≦ 0.5</td></tr></table> | <table><tr><td>Gentamicin</td><td>≦ 1</td></tr><tr><td>Levofloxacin</td><td>≦ 0.25</td></tr><tr><td>Imipenem</td><td>≦ 0.5</td></tr><tr><td>Meropenem</td><td>≦ 0.5</td></tr><tr><td>Piperacillin/tazobactam</td><td>≦ 2</td></tr><tr><td>Trimethoprim/sulfamethoxazole</td><td>≦ 5</td></tr></table> |
f0fa278f7fce0b78ebc5a5a3b17fca944db6d8d093326de107b4a2c16336ecab.png | simple | <table><tr><td>Clinical analysis</td><td>Number</td><td>Percentage (%)</td></tr><tr><td>Clinical phenotype</td><td>212</td><td> </td></tr><tr><td> DMD</td><td>148</td><td>69.81%</td></tr><tr><td> BMD</td><td>52</td><td>24.53%</td></tr><tr><td> IMD</td><td>12</td><td>5.66%</td></tr><tr><td>Blood test</td><td>190</td><td... | <table><tr><td>Clinical analysis</td><td>Number</td><td>Percentage (%)</td></tr><tr><td>Clinical phenotype</td><td>212</td><td></td></tr><tr><td>DMD</td><td>148</td><td>69.81%</td></tr><tr><td>BMD</td><td>52</td><td>24.53%</td></tr><tr><td>IMD</td><td>12</td><td>5.66%</td></tr><tr><td>Blood test</td><td>190</td><td></t... | <table><tr><td>Clinical analysis</td><td>Number</td><td>Percentage (%)</td></tr><tr><td>Large rearrangements</td><td>136</td><td>9.74%</td></tr><tr><td>Smaller mutations</td><td>42</td><td>21.54%</td></tr><tr><td>No large rearrangements</td><td>17</td><td>8.72%</td></tr></table> |
2ef82242ce99dfd8c744e4f07ce21968e38c4dd076cb3236a045ecd9026d91cd.png | complex | <table><tr><td rowspan="2">Noise type</td><td rowspan="2">Noise reduction technique</td><td colspan="7">Noise intensity (dB)</td></tr><tr><td>20</td><td>18</td><td>16</td><td>14</td><td>12</td><td>10</td><td>8</td></tr><tr><td>Gaussian</td><td>Wavelet</td><td>90.71</td><td>90.00</td><td>90.36</td><td>87.86</td><td>88.5... | <table><tr><td rowspan="2">Noise type</td><td rowspan="2">Noise reduction technique</td><td colspan="7">Noise intensity (dB)</td></tr><tr><td>20</td><td>18</td><td>16</td><td>14</td><td>12</td><td>10</td><td>8</td></tr></table> | <table><tr><td>Gaussian</td><td>Wavelet</td><td>90.71</td><td>90.00</td><td>90.36</td><td>87.86</td><td>88.57</td><td>86.07</td><td>71.79</td></tr><tr><td></td><td>Contourlet</td><td>89.29</td><td>88.57</td><td>87.50</td><td>87.51</td><td>78.93</td><td>65.00</td><td>44.64</td></tr><tr><td></td><td>TV</td><td>87.14</td>... |
60130a963a1aa821f16d1c46d7342aaf92942d09d1cee7b96d927bcce5c324f0.png | simple | <table><tr><td>Swiss Prot Acc. No.</td><td>Symbol</td><td>Entrez Gene Name</td><td>Fold Change</td><td>Location</td><td>Protein Class</td></tr><tr><td>P08758</td><td>ANXA5</td><td>annexin A5</td><td>-1.98</td><td>Plasma membrane</td><td>transfer/carrier protein</td></tr><tr><td>Q07507</td><td>DPT</td><td>dermatopontin<... | <table><tr><td>Swiss Prot Acc. No.</td><td>Symbol</td><td>Entrez Gene Name</td><td>Fold Change</td><td>Location</td><td>Protein Class</td></tr><tr><td>P08758</td><td>ANXA5</td><td>annexin A5</td><td>-1.98</td><td>Plasma membrane</td><td>transfer/carrier protein</td></tr><tr><td>Q07507</td><td>DPT</td><td>dermatopontin<... | <table><tr><td>Swiss Prot Acc. No.</td><td>Symbol</td><td>Entrez Gene Name</td><td>Fold Change</td><td>Location</td><td>Protein Class</td></tr><tr><td>62917</td><td>8</td><td>ein L8</td><td>-1.76</td><td>plasm</td><td>ibosomal protein</td></tr></table> |
21f7dfe0120290809152c396de7380c34f6c457b8aee7edbb18aa196fc2e5697.png | simple | <table><tr><td>Primer</td><td>Sequence (5′-3′)</td></tr><tr><td>FLAG-NS1-F</td><td>CAGAATTCTAATGGATTCCAACACTGTG (EcoRI)</td></tr><tr><td>FLAG-NS1-R</td><td>GGGGTACCCACTTCTGACTCAATTGTTC (KpnI)</td></tr><tr><td>HA-ANXA2-F</td><td>GGGGTACCCCGTCTACTGTTCACGAAATCCTG (KpnI)</td></tr><tr><td>HA-ANXA2-R</td><td>GAAG... | <table><tr><td>Primer</td></tr><tr><td>FLAG-NS1-F</td></tr><tr><td>FLAG-NS1-R</td></tr><tr><td>HA-ANXA2-F</td></tr><tr><td>HA-ANXA2-R</td></tr><tr><td>ANXA2-159F</td></tr><tr><td>ANXA2-159R</td></tr><tr><td>GAPDH-F</td></tr><tr><td>GAPDH-R</td></tr></table> | <table><tr><td>Sequence (5′-3′)</td></tr><tr><td>CAGAATTCTAATGGATTCCAACACTGTG (EcoRI)</td></tr><tr><td>GGGGTACCCACTTCTGACTCAATTGTTC (KpnI)</td></tr><tr><td>GGGGTACCCCGTCTACTGTTCACGAAATCCTG (KpnI)</td></tr><tr><td>GAAGATCTTCGTCATCTCCACCACACAGGTA (BglII)</td></tr><tr><td>TGGATGAGGTCACCATTGTCA</td></tr><tr><td>TCAATAGGCCC... |
e3224b10dbf2498c5dfd969ae371eb0dddd973fd9857066ee2f537376ce12544.png | simple | <table><tr><td></td><td>Stabilizer</td><td>DLC (%)</td><td>EE (%)</td></tr><tr><td>Abm-NPs-1</td><td>PLGA-<i>b</i>-PEG</td><td>41.46 ± 0.05</td><td>96.74 ± 0.12</td></tr><tr><td>Abm-NPs-2</td><td>PLA-<i>b</i>-PEG</td><td>40.97 ± 0.05</td><td>95.60 ± 0.11</td></tr><tr><td>Abm-NPs-3</td><td>PCL-<i>b</... | <table><tr><td></td></tr><tr><td>Abm-NPs-1</td></tr><tr><td>Abm-NPs-2</td></tr><tr><td>Abm-NPs-3</td></tr></table> | <table><tr><td>Stabilizer</td><td>DLC (%)</td><td>EE (%)</td></tr><tr><td>PLGA-b-PEG</td><td>41.46 ± 0.05</td><td>96.74 ± 0.12</td></tr><tr><td>PLA-b-PEG</td><td>40.97 ± 0.05</td><td>95.60 ± 0.11</td></tr><tr><td>PCL-b-PEG</td><td>40.76 ± 0.03</td><td>95.10 ± 0.07</td></tr></table> |
21f3a98296591d05375830beed4488bb7591fbc5cbe1dc7080c40c229eb9ead5.png | simple | <table><tr><td></td><td>All childrena (<i>n</i> = 838)</td><td>Female (<i>n</i> = 405)</td><td>Male (<i>n</i> = 433)</td></tr><tr><td></td><td>Frequency (%)</td><td>Frequency (%)</td><td>Frequency (%)</td></tr><tr><td>No. of years of schooling (<i>y</i>)</td><td></td><td></td><td></td></tr><tr><td>0</td><td>14 (1.7)</t... | <table><tr><td></td><td>All childrena (n = 838)</td><td>Female (n = 405)</td><td>Male (n = 433)</td></tr><tr><td></td><td>Frequency (%)</td><td>Frequency (%)</td><td>Frequency (%)</td></tr><tr><td>No. of years of schooling (y)</td><td></td><td></td><td></td></tr><tr><td>0</td><td>14 (1.7)</td><td>6 (1.5)</td><td>8 (1.8... | <table><tr><td></td><td>All childrena (n = 838)</td><td>Female (n = 405)</td><td>Male (n = 433)</td></tr><tr><td></td><td>Frequency (%)</td><td>Frequency (%)</td><td>Frequency (%)</td></tr><tr><td>Schooling years, categorized</td><td></td><td></td><td></td></tr><tr><td>≤2 y</td><td>143 (17.1)</td><td>67 (16.5)</td><td>... |
7b7a5e0e90ba8224623a21cd5c71ba1b6c7e33e4193706012ef484e455e50f38.png | complex | <table><tr><td></td><td colspan="2">Model 1</td><td colspan="2">Model 2</td><td colspan="2">Model 3</td></tr><tr><td>Explanatory variables</td><td>OR (95% CI)</td><td>P</td><td>OR (95% CI)</td><td>P</td><td>OR (95% CI)</td><td>P</td></tr><tr><td>PTH</td><td>1.69 (1.12–2.56)</td><td>0.013</td><td>2.25 (1.34–... | <table><tr><td></td><td colspan="2">Model 1</td><td colspan="2">Model 2</td><td colspan="2">Model 3</td></tr></table> | <table><tr><td>Explanatory variables</td><td>OR (95% CI)</td><td>P</td><td>OR (95% CI)</td><td>P</td><td>OR (95% CI)</td><td>P</td></tr><tr><td>PTH</td><td>1.69 (1.12–2.56)</td><td>0.013</td><td>2.25 (1.34–3.78)</td><td>0.002</td><td>2.62 (1.52–4.53)</td><td>0.001</td></tr><tr><td>25(OH)D</td><td>0.86 (0.62–1.20)</td><... |
c9d3236612fe3d3a7b01927fba667526972eae7362edb0e1c6031785d70847cf.png | simple | <table><tr><td>Transposon</td><td>Primer 5'-3'</td><td><i>Tm </i>(°C)</td></tr><tr><td>IAP-RTF1</td><td>TCAAGGACAGGGTATTGTTG</td><td>For reverse transcription</td></tr><tr><td>IAP-RTR2</td><td>TATTGACGCCCTGGACATCAC</td><td>For reverse transcription</td></tr><tr><td>IAP-PCRF3</td><td>GGGTATTGTTGAGCGTGCGC</td><td>56... | <table><tr><td>Transposon</td><td>Primer 5'-3'</td><td>Tm (°C)</td></tr><tr><td>IAP-RTF1</td><td>TCAAGGACAGGGTATTGTTG</td><td>For reverse transcription</td></tr><tr><td>IAP-RTR2</td><td>TATTGACGCCCTGGACATCAC</td><td>For reverse transcription</td></tr><tr><td>IAP-PCRF3</td><td>GGGTATTGTTGAGCGTGCGC</td><td>56</td></tr></... | <table><tr><td>IAP-PCRR4</td><td>TCGGGTGAGTCTTTCTGGTAC</td><td>56</td></tr><tr><td>MuERV-RTF1</td><td>CAAAGTGGCCATGGTGGTCG</td><td>For reverse transcription</td></tr><tr><td>MuERV-RTR2</td><td>GTACCATATATCGAGCGCTG</td><td>For reverse transcription</td></tr><tr><td>MuERV-PCRF3</td><td>TGCTTGGGCTCAGCAACATGG</td><td>56</t... |
69a0fe8c7c224169bb86241ac09dde0b4a4a7f4dcf05c44241e1c865daaa2b3d.png | complex | <table><tr><td>Variable</td><td>Deceased patients<i>n</i> = 91</td><td>Surviving patients<i>n</i> = 1660</td><td><i>P</i> value</td></tr><tr><td>Age [years (mean ± SD)]</td><td>54 ± 17</td><td>45 ± 15</td><td><0.0001</td></tr><tr><td>Male gender [<i>n</i> (%)]</td><td>46 (51)</td><td>766 (46)</td><td>... | <table><tr><td>Variable</td><td>Deceased patientsn = 91</td><td>Surviving patientsn = 1660</td><td>P value</td></tr><tr><td>Age [years (mean ± SD)]</td><td>54 ± 17</td><td>45 ± 15</td><td><0.0001</td></tr><tr><td>Male gender [n (%)]</td><td>46 (51)</td><td>766 (46)</td><td>0.42</td></tr><tr><td>SAPS II score, points (m... | <table><tr><td>Alone</td><td>15 (16)</td><td>1067 (64)</td><td><0.0001</td></tr><tr><td>And/or with non-psychoactive medications</td><td>10 (11)</td><td>129 (8)</td><td>0.27</td></tr><tr><td>And/or with pesticides, household, or industrial products</td><td>0 (0)</td><td>28 (2)</td><td>0.40</td></tr><tr><td>And/or with ... |
7b9ddbb490f5f84be3322066c979caf63c9a7589853cb779187866e4c4a3deff.png | simple | <table><tr><td></td><td>Overweight*</td><td>Body fat (%)<sup>+</sup></td><td>Lean body mass (kg)<sup>+</sup></td></tr><tr><td>Birth weight (z)</td><td>1.13 (1.03 to 1.25)</td><td>0.03 (−0.26 to 0.32)</td><td>1.66 (1.36 to 1.95)</td></tr><tr><td> <i>P </i>for trend</td><td>0.01</td><td>0.8</td><td><0.001</td></... | <table><tr><td></td></tr><tr><td>Birth weight (z)</td></tr><tr><td>P for trend</td></tr><tr><td>Ponderal index (z)</td></tr><tr><td>P for trend</td></tr><tr><td>Placental weight (z)</td></tr><tr><td>P for trend</td></tr><tr><td>Max placental diam (z)</td></tr><tr><td>p for trend</td></tr><tr><td>Lesser placental diam (... | <table><tr><td>Overweight*</td><td>Body fat (%)+</td><td>Lean body mass (kg)+</td></tr><tr><td>1.13 (1.03 to 1.25)</td><td>0.03 (−0.26 to 0.32)</td><td>1.66 (1.36 to 1.95)</td></tr><tr><td>0.01</td><td>0.8</td><td><0.001</td></tr><tr><td>1.12 (1.01 to 1.23)</td><td>0.28 (−0.01 to 0.57)</td><td>0.40 (0.10 to 0.71)</td><... |
b53bb94e0e5ae7185e019cfb59cd94e82cb13a5e8345224da2c7637e5203c73f.png | simple | <table><tr><td>Comorbidities</td><td>ICD-9-CM codes</td></tr><tr><td>Schizophrenia</td><td>295.XX</td></tr><tr><td>Bipolar disorder</td><td>296.01, 296.02, 296.03, 296.04, 296.05, 296.06, 296.40, 296.41, 296.42, 296.43, 296.44, 296.45, 296.46, 296.50, 296.51, 296.52, 296.53, 296.54, 296.55, 296.56, 296.60, 296.61, 296.... | <table><tr><td>Comorbidities</td></tr><tr><td>Schizophrenia</td></tr><tr><td>Bipolar disorder</td></tr><tr><td>Major depressive disorder</td></tr><tr><td>Substance abuse</td></tr><tr><td>Hypertension</td></tr><tr><td>Hyperlipidemia</td></tr><tr><td>Diabetes</td></tr><tr><td>Chronic obstructive pulmonary disease</td></t... | <table><tr><td>ICD-9-CM codes</td></tr><tr><td>295.XX</td></tr><tr><td>296.01, 296.02, 296.03, 296.04, 296.05, 296.06, 296.40, 296.41, 296.42, 296.43, 296.44, 296.45, 296.46, 296.50, 296.51, 296.52, 296.53, 296.54, 296.55, 296.56, 296.60, 296.61, 296.62, 296.63, 296.64, 296.65, 296.66, 296.7, 296.80, 296.89</td></tr><t... |
311e3494f9febf2458dd80eaa01cd93e4bc4571316adc37ca7e83afb152b3cae.png | simple | <table><tr><td>Paper</td><td>CMR parameters<sup>a</sup></td><td>Description of aneurysm</td></tr><tr><td>Contreras et al. [18]</td><td>Steady-state free precession</td><td>None provided</td></tr><tr><td>Corti et al. [12]</td><td>Turbo field-echo movie reconstruction</td><td>Dimensions: 7 × 5 × 3.5 cm2.8 cm os... | <table><tr><td>Paper</td><td>CMR parametersa</td></tr><tr><td>Contreras et al. [18]</td><td>Steady-state free precession</td></tr><tr><td>Corti et al. [12]</td><td>Turbo field-echo movie reconstruction</td></tr><tr><td>Duran et al. [21]</td><td>Not specified</td></tr><tr><td>Guaricci et al. [10]</td><td>Not specified</... | <table><tr><td>Description of aneurysm</td></tr><tr><td>None provided</td></tr><tr><td>Dimensions: 7 × 5 × 3.5 cm2.8 cm ostiumRight ventricular compressionSysto-diastolic filling of the mass consistent with right atrial filling</td></tr><tr><td>Dimensions: 2.5 × 1.5 cm over the tricuspid valveNeck: 11 mmNo thrombus</td... |
ab3dcda09336ede7cfeeca4c0d9defa41b23cae09a43ff8db682f16b72586abe.png | simple | <table><tr><td>Chrom</td><td>Chrom length</td><td># genes</td><td>gene density</td><td># differentially expressed</td><td>% differentially expressed</td><td>up in ko</td><td>down in ko</td><td>fraction up in ko</td></tr><tr><td>1</td><td>197195432</td><td>1272</td><td>155028</td><td>412</td><td>32.4</td><td>134</td><td... | <table><tr><td>Chrom</td><td>Chrom length</td><td># genes</td><td>gene density</td><td># differentially expressed</td><td>% differentially expressed</td><td>up in ko</td><td>down in ko</td><td>fraction up in ko</td></tr><tr><td>1</td><td>197195432</td><td>1272</td><td>155028</td><td>412</td><td>32.4</td><td>134</td><td... | <table><tr><td>3</td><td>159599783</td><td>1071</td><td>149019</td><td>306</td><td>28.6</td><td>98</td><td>208</td><td>0.32</td></tr><tr><td>4</td><td>155630120</td><td>1410</td><td>110376</td><td>402</td><td>28.5</td><td>151</td><td>251</td><td>0.38</td></tr><tr><td>5</td><td>152537259</td><td>1339</td><td>113919</td>... |
f694f1059c6eae9ad9cca45d995ceb3550ca1ae697d87a1415c1a5c80636254c.png | complex | <table><tr><td></td><td></td><td colspan="4">ELISA Antigen Titer after Four iImmunizations *</td></tr><tr><td>Animal a</td><td>Immunogen</td><td>Bridging Sheet</td><td>gp120-SF162</td><td>gp140DV2-SF162</td><td>E2 Protein</td></tr><tr><td>Mouse1</td><td>E2-BS1</td><td>100,000</td><td><20</td><td>--</td><td>500,000</... | <table><tr><td></td><td></td><td colspan="4">ELISA Antigen Titer after Four iImmunizations *</td></tr><tr><td>Animal a</td><td>Immunogen</td><td>Bridging Sheet</td><td>gp120-SF162</td><td>gp140DV2-SF162</td><td>E2 Protein</td></tr><tr><td>Mouse1</td><td>E2-BS1</td><td>100,000</td><td><20</td><td>--</td><td>500,000</td>... | <table><tr><td>e2</td><td>-BS1</td><td>0,000</td><td><20</td><td></td><td>0,000</td></tr><tr><td>Mouse3</td><td>E2-BS1</td><td>50,000</td><td><20</td><td>--</td><td>500,000</td></tr><tr><td>Mouse4</td><td>E2</td><td><20</td><td><20</td><td>--</td><td>1,000,000</td></tr><tr><td>Mouse5</td><td>E2</td><td><20</td><td><20<... |
8217970aff4821ff39338913f94839b88c3bdd3c6806d7d78da17c0ad1474be3.png | complex | <table><tr><td></td><td>2012</td><td>2013</td><td>2014</td><td>Overall</td></tr><tr><td colspan="5">Dog vaccination costs for Laoag City</td></tr><tr><td>Total cost of dog vaccination (PHP)</td><td>1,110,365</td><td>1,040,485</td><td>1,054,202</td><td>3,205,053</td></tr><tr><td>Total cost of dog vaccination (USD)</td><... | <table><tr><td></td><td>2012</td><td>2013</td><td>2014</td><td>Overall</td></tr><tr><td colspan="5">Dog vaccination costs for Laoag City</td></tr><tr><td>Total cost of dog vaccination (PHP)</td><td>1,110,365</td><td>1,040,485</td><td>1,054,202</td><td>3,205,053</td></tr><tr><td>Total cost of dog vaccination (USD)</td><... | <table><tr><td>Total cost for PEP (PHP)</td><td>183,976</td><td>404,390</td><td>755,128</td><td>1,343,494</td></tr><tr><td>Total cost for PEP (USD)</td><td>4,047</td><td>8,897</td><td>16,613</td><td>29,557</td></tr><tr><td>Number of PEP doses provided</td><td>202</td><td>507</td><td>1,207</td><td>1,917</td></tr><tr><td... |
9b51fbaa5081474368daf33ec7167a16a3c5816e8090ba50e7953cf102fff8c0.png | simple | <table><tr><td>Localization sites</td><td>No.</td></tr><tr><td>cytoplasmic</td><td>248</td></tr><tr><td>inner membrane</td><td>268</td></tr><tr><td>periplasmic</td><td>244</td></tr><tr><td>outmembrane</td><td>352</td></tr><tr><td>extracellular</td><td>190</td></tr><tr><td>cytoplasmic / inner membrane</td><td>14</td></t... | <table><tr><td>Localization sites</td><td>No.</td></tr></table> | <table><tr><td>cytoplasmic</td><td>248</td></tr><tr><td>inner membrane</td><td>268</td></tr><tr><td>periplasmic</td><td>244</td></tr><tr><td>outmembrane</td><td>352</td></tr><tr><td>extracellular</td><td>190</td></tr><tr><td>cytoplasmic / inner membrane</td><td>14</td></tr><tr><td>membrane / periplasmic</td><td>49</td>... |
a3411aad5e8ec2ef053c0730d2da36f53d2eb873b33105319abd4aa50504fd5b.png | simple | <table><tr><td>MIF overexpression</td><td>Comments</td><td>Ref</td></tr><tr><td>Childhood rhabdomyosarcoma</td><td>Human RMS cells express and secrete MIF</td><td>[137]</td></tr><tr><td>Melanoma</td><td>MIF levels increase in advanced stages</td><td>[18]</td></tr><tr><td>Uveal melanoma</td><td>MIF prevents NK cell-medi... | <table><tr><td>MIF overexpression</td><td>Comments</td><td>Ref</td></tr><tr><td>Childhood rhabdomyosarcoma</td><td>Human RMS cells express and secrete MIF</td><td>[137]</td></tr><tr><td>Melanoma</td><td>MIF levels increase in advanced stages</td><td>[18]</td></tr><tr><td>Uveal melanoma</td><td>MIF prevents NK cell-medi... | <table><tr><td>Malignant glioma</td><td>MIF levels increase wuth tumor gradeMIF counteract NK cell-mediated lysis</td><td>[83]</td></tr><tr><td>Lung adenocarcinoma</td><td>MIF distribution predicts patient prognosis</td><td>[38]</td></tr><tr><td>Non-small cell lung cancer</td><td>Higher MIF levels are found in tumor ti... |
31dc4e86c5e7a4358a29dcacf273fc58f995f37036f854933288f173d68d13c7.png | complex | <table><tr><td rowspan="2"></td><td rowspan="2">DN</td><td rowspan="2">GN</td><td rowspan="2">GO</td><td rowspan="2">Control</td><td>ANOVA</td></tr><tr><td><i>P</i> value</td></tr><tr><td>AST (IU/L)</td><td>353.7 ± 165.45</td><td>403.4 ± 169.31</td><td>363.4 ± 174.53</td><td>273.0 ± 193.34</td><td>0... | <table><tr><td rowspan="2"></td><td rowspan="2">DN</td><td rowspan="2">GN</td><td rowspan="2">GO</td><td rowspan="2">Control</td><td>ANOVA</td></tr><tr><td>P value</td></tr><tr><td>AST (IU/L)</td><td>353.7 ± 165.45</td><td>403.4 ± 169.31</td><td>363.4 ± 174.53</td><td>273.0 ± 193.34</td><td>0.861</td></tr><tr><td>ALT (... | <table><tr><td>IU/L)</td><td></td><td>1.57</td><td>182.8a ± 25.74</td><td>175.5a ± 25.08</td><td>000</td></tr><tr><td>Glucose (mg/dL)</td><td>145.7 b ± 32.89</td><td>138.1b ± 19.78</td><td>144.4b ± 24.59</td><td>218.8a ± 56.77</td><td>0.003</td></tr><tr><td>Creatinine (mg/dL)</td><td>0.36a ± 0.205</td><td>0.29b ± 0.147... |
02b13d7a86b8cccdd02f5873cc922e9de9c34f2e95f60111573287a4395952cc.png | complex | <table><tr><td rowspan="2">Characteristics</td><td>Total</td><td rowspan="2">n<sup>d</sup> (%)</td><td></td><td colspan="2">Physical activity</td><td></td></tr><tr><td>N</td><td>COR(95%CI)</td><td><i>P</i> Value</td><td>AOR(95%CI)</td><td><i>P</i> value</td></tr><tr><td>Total</td><td>3600</td><td>3411 (94.7)</td><td></... | <table><tr><td rowspan="2">Characteristics</td><td>Total</td><td rowspan="2">nd (%)</td><td></td><td colspan="2">Physical activity</td><td></td></tr><tr><td>N</td><td>COR(95%CI)</td><td>P Value</td><td>AOR(95%CI)</td><td>P value</td></tr><tr><td>Total</td><td>3600</td><td>3411 (94.7)</td><td></td><td></td><td></td><td>... | <table><tr><td rowspan="2">Characteristics</td><td>Total</td><td rowspan="2">nd (%)</td><td></td><td colspan="2">Physical activity</td><td></td></tr><tr><td>N</td><td>COR(95%CI)</td><td>P Value</td><td>AOR(95%CI)</td><td>P value</td></tr><tr><td></td><td></td><td> (95.3)</td><td>1.24 (0.86–1.79)</td><td>32</td><td></td... |
a1d1926e2e561d3127dc3319fdf47f12491d07b5952ee2d689712496c2c4838f.png | complex | <table><tr><td rowspan="2">Characteristic</td><td rowspan="2">Newly diagnosed (age > 14 years old)</td><td colspan="2">Initial CD4 cell count within one month</td><td colspan="2">Initial CD4 cell count within one year</td><td colspan="2">Initial CD4 cell counts < 200 cell/ul within one year</td></tr><tr><td>n</td... | <table><tr><td rowspan="2">Characteristic</td><td rowspan="2">Newly diagnosed (age > 14 years old)</td><td colspan="2">Initial CD4 cell count within one month</td><td colspan="2">Initial CD4 cell count within one year</td><td colspan="2">Initial CD4 cell counts < 200 cell/ul within one year</td></tr><tr><td>n</td><td>%... | <table><tr><td rowspan="2">Characteristic</td><td rowspan="2">Newly diagnosed (age > 14 years old)</td><td colspan="2">Initial CD4 cell count within one month</td><td colspan="2">Initial CD4 cell count within one year</td><td colspan="2">Initial CD4 cell counts < 200 cell/ul within one year</td></tr><tr><td>n</td><td>%... |
3673d7be470c3d03cdd9d12eb80106145f80fd0cbb0f0725cbf0d2be349f1d6c.png | complex | <table><tr><td rowspan="2">Mycotoxin</td><td rowspan="2">Correlation Coefficient (r)</td><td colspan="2">Repeatability (RSD<sub>r</sub>, %) <sup>a</sup></td><td colspan="2">Reproducibility (RSD<sub>R</sub>, %) <sup>a</sup></td><td rowspan="2">LOD (ng/g)</td><td rowspan="2">LOQ (ng/g)</td><td rowspan="2">SSE (%)</td></t... | <table><tr><td rowspan="2">Mycotoxin</td><td rowspan="2">Correlation Coefficient (r)</td><td colspan="2">Repeatability (RSDr, %) a</td><td colspan="2">Reproducibility (RSDR, %) a</td><td rowspan="2">LOD (ng/g)</td><td rowspan="2">LOQ (ng/g)</td><td rowspan="2">SSE (%)</td></tr><tr><td>25 ng/g b</td><td>50 ng/g b</td><t... | <table><tr><td>AOH</td><td>0.998</td><td>81 (6)</td><td>82 (4)</td><td>84 (8)</td><td>89 (6)</td><td>1.40</td><td>3.50</td><td>65</td></tr><tr><td>AME</td><td>0.996</td><td>86 (4)</td><td>89 (7)</td><td>90 (7)</td><td>93 (10)</td><td>1.40</td><td>3.50</td><td>80</td></tr><tr><td>TEN</td><td>0.995</td><td>91 (9)</td><td... |
066532c0ff0db1e6199505a0a094492e2ea83cd6a1e1d41ea647a2534c00914e.png | complex | <table><tr><td rowspan="2">Number of requests</td><td colspan="2">One Tomcat server</td><td colspan="2">Two Tomcat servers</td></tr><tr><td>Mean time (seconds)</td><td>Total time (seconds)</td><td>Mean time (seconds)</td><td>Total time (seconds)</td></tr><tr><td>1</td><td>1.661</td><td>1.661</td><td>1.994</td><td>1.994... | <table><tr><td rowspan="2">Number of requests</td><td colspan="2">One Tomcat server</td><td colspan="2">Two Tomcat servers</td></tr><tr><td>Mean time (seconds)</td><td>Total time (seconds)</td><td>Mean time (seconds)</td><td>Total time (seconds)</td></tr><tr><td>1</td><td>1.661</td><td>1.661</td><td>1.994</td><td>1.994... | <table><tr><td>50</td><td>1.380</td><td>69</td><td>1.140</td><td>57</td></tr><tr><td>60</td><td>1.367</td><td>82</td><td>1.150</td><td>69</td></tr><tr><td>70</td><td>1.371</td><td>96</td><td>1.157</td><td>81</td></tr><tr><td>80</td><td>1.400</td><td>112</td><td>1.275</td><td>102</td></tr><tr><td>90</td><td>1.489</td><t... |
4976468e6f5dcfa882fb3789474753aa16291cd8f360ee61981ca4a406f1aa2d.png | simple | <table><tr><td>Burnout Subscale</td><td>Low</td><td>Moderate</td><td>High</td></tr><tr><td>Emotional exhaustion</td><td>37 (34%)</td><td>39 (35%)</td><td>34 (31%)</td></tr><tr><td>Depersonalization</td><td>93 (77%)</td><td>22 (18%)</td><td>6 (5%)</td></tr><tr><td>Personal accomplishment</td><td>42 (45%)</td><td>26 (28%... | <table><tr><td>Burnout Subscale</td><td>Low</td></tr><tr><td>Emotional exhaustion</td><td>37 (34%)</td></tr><tr><td>Depersonalization</td><td>93 (77%)</td></tr><tr><td>Personal accomplishment</td><td>42 (45%)</td></tr></table> | <table><tr><td>Moderate</td><td>High</td></tr><tr><td>39 (35%)</td><td>34 (31%)</td></tr><tr><td>22 (18%)</td><td>6 (5%)</td></tr><tr><td>26 (28%)</td><td>25 (27%)</td></tr></table> |
0c0057242a4f680f2e650161c7156d2e8260c80bc63bcb7175cb45bceeeebceb.png | complex | <table><tr><td rowspan="2">Gene</td><td rowspan="2">Genotype</td><td>Time to progression</td><td rowspan="2">HR (95% CI)</td><td rowspan="2"><i>p</i></td><td>Overall survival</td><td rowspan="2">HR (95% CI)</td><td rowspan="2"><i>p</i></td></tr><tr><td>Median (25%–75%)</td><td>Median (25%–75%)</td></tr><tr>... | <table><tr><td rowspan="2">Gene</td><td rowspan="2">Genotype</td><td>Time to progression</td><td rowspan="2">HR (95% CI)</td><td rowspan="2">p</td><td>Overall survival</td><td rowspan="2">HR (95% CI)</td><td rowspan="2">p</td></tr><tr><td>Median (25%–75%)</td><td>Median (25%–75%)</td></tr><tr><td>MMP2</td><td></td><td>... | <table><tr><td rowspan="4">rs20544</td><td>CC</td><td>7.53 (5.53–11.53)</td><td>Ref.</td><td></td><td>13.50 (8.13–21.20)</td><td>Ref.</td><td></td></tr><tr><td>CT</td><td>10.93 (7.37–19.97)</td><td>0.60 (0.40–0.90)</td><td>0.014</td><td>20.67 (11.33–32.53)</td><td>0.59 (0.39–0.91)</td><td>0.018</td></tr><tr><td>TT</td>... |
1f215c98adae14e1f867feca9b523cabddf001c8d90700ca5817179cdac0c4aa.png | simple | <table><tr><td>Gene associated with presence in East Asia clade and absence in USA clade</td><td>Antibiotic(s) to which resistance conferred</td></tr><tr><td><i>catA</i></td><td>Chloramphenicol</td></tr><tr><td><i>ermB</i></td><td>Macrolides, lincosamides, streptogramins B</td></tr><tr><td><i>mecA</i></td><td>Beta-lact... | <table><tr><td>Gene associated with presence in East Asia clade and absence in USA clade</td><td>Antibiotic(s) to which resistance conferred</td></tr><tr><td>catA</td><td>Chloramphenicol</td></tr><tr><td>ermB</td><td>Macrolides, lincosamides, streptogramins B</td></tr><tr><td>mecA</td><td>Beta-lactams</td></tr><tr><td>... | <table><tr><td>Gene associated with presence in East Asia clade and absence in USA clade</td><td>Antibiotic(s) to which resistance conferred</td></tr><tr><td>ant(6)-Ia</td><td>Aminoglycosides</td></tr><tr><td>aph(3)-III</td><td>Aminoglycosides</td></tr></table> |
9d713993fc43663930489426094863a64057b264d5d407efe9ac665945437f1b.png | simple | <table><tr><td>Transcript(Primer Name)</td><td>Forward Primer</td><td>Reverse Primer</td><td>Product Size</td></tr><tr><td>H. E4BP4(HUMANE4BP4-742 & 991)</td><td>5'ATGGGGAATTCTTTCTCTGG3'</td><td>5'CTTTGATCCGGAGCTTGTGT3'</td><td>250 bp</td></tr><tr><td>M. E4BP4(Mouse E4BP4-742 &1117)</td><td>5'ATGGGAAGCTCTTTCTCC... | <table><tr><td>Transcript(Primer Name)</td><td>Forward Primer</td><td>Reverse Primer</td><td>Product Size</td></tr><tr><td>H. E4BP4(HUMANE4BP4-742 & 991)</td><td>5'ATGGGGAATTCTTTCTCTGG3'</td><td>5'CTTTGATCCGGAGCTTGTGT3'</td><td>250 bp</td></tr><tr><td>M. E4BP4(Mouse E4BP4-742 &1117)</td><td>5'ATGGGAAGCTCTTTCTCCACT3'</t... | <table><tr><td>Bim(BIM 5/6 SENSE & ANTI)</td><td>5'CAGATATGCGCCCAGAGATA3'</td><td>5'ACCAGGCGGACAATGTAAC3'</td><td>163 bp</td></tr><tr><td>Puma(PUMA SENSE & ANTI)</td><td>5'AAGAGCAAATGAGCCAAACG3'</td><td>5'GCAGAGCACAGGATTCACAG3'</td><td>181 bp</td></tr><tr><td>β-actin(B-ACTIN-130 SENSE & ANTI)</td><td>5'AGTCCTCTCCCAAGTC... |
401e1231d508617d7b11a0ed6c974450b3d632e909cd0cc1ab956d52754e4a66.png | simple | <table><tr><td>Variable</td><td>18–49 years(<i>n</i> = 263)</td><td>50–64 years(<i>n</i> = 142)</td><td>65+ years(<i>n</i> = 77)</td><td>Chi-Square<i>P</i>-value</td></tr><tr><td>Exhaustion (% yes)</td><td>139 (52.9%)</td><td>34 (24.0%)</td><td>8 (11.0%)</td><td><0.001</td></tr><tr><td>Physical activity ... | <table><tr><td>Variable</td><td>18–49 years(n = 263)</td><td>50–64 years(n = 142)</td><td>65+ years(n = 77)</td><td>Chi-SquareP-value</td></tr><tr><td>Exhaustion (% yes)</td><td>139 (52.9%)</td><td>34 (24.0%)</td><td>8 (11.0%)</td><td><0.001</td></tr><tr><td>Physical activity (% inactive)a</td><td>-</td><td>-</td><td>-... | <table><tr><td>h (% yes)</td><td>2.6%)</td><td>%)</td><td>9 (11.9%)</td><td>0.001</td></tr></table> |
c00428d674d41ed1b772191c40285c512193917bd495dc97e7569eb5e744aa84.png | simple | <table><tr><td>Clinical manifestations</td><td>Kidney and ureter stones</td><td>Simple kidney stones</td><td>Unilateral ureteral calculi</td><td>Simple bilateral ureteral calculi</td><td>Bladder calculi</td><td>Urinary tract stones</td><td>Total</td></tr><tr><td>Anuria</td><td>13</td><td>1</td><td>1</td><td>5</td><td>1... | <table><tr><td>Clinical manifestations</td><td>Kidney and ureter stones</td><td>Simple kidney stones</td><td>Unilateral ureteral calculi</td></tr><tr><td>Anuria</td><td>13</td><td>1</td><td>1</td></tr><tr><td>Oliguria</td><td>1</td><td>0</td><td>0</td></tr><tr><td>Dysuria</td><td>0</td><td>0</td><td>0</td></tr><tr><td>... | <table><tr><td>Simple bilateral ureteral calculi</td><td>Bladder calculi</td><td>Urinary tract stones</td><td>Total</td></tr><tr><td>5</td><td>1</td><td>0</td><td>21</td></tr><tr><td>0</td><td>1</td><td>0</td><td>2</td></tr><tr><td>0</td><td>0</td><td>2</td><td>2</td></tr><tr><td>0</td><td>1</td><td>0</td><td>3</td></t... |
3775313ca5ac61261170f61b27290980b7aafef5978f7115a1befadf1d1ec240.png | simple | <table><tr><td>Questions:</td><td>T0 Mean ± SD</td><td>T1 Mean ± SD</td></tr><tr><td>Training/learning to use the device is not complicated</td><td>4.67 ± 0.58</td><td>4.33 ± 0.58</td></tr><tr><td>Wearing/adjusting the device is relatively simple</td><td>4.33 ± 0.58</td><td>4.33 ± 1.15</td... | <table><tr><td>Questions:</td></tr><tr><td>Training/learning to use the device is not complicated</td></tr><tr><td>Wearing/adjusting the device is relatively simple</td></tr><tr><td>It was comfortable to exercise with the device</td></tr><tr><td>The usage of the device did not cause considerable pain</td></tr><tr><td>I... | <table><tr><td>T0 Mean ± SD</td><td>T1 Mean ± SD</td></tr><tr><td>4.67 ± 0.58</td><td>4.33 ± 0.58</td></tr><tr><td>4.33 ± 0.58</td><td>4.33 ± 1.15</td></tr><tr><td>4.67 ± 0.58</td><td>4.33 ± 0.58</td></tr><tr><td>5.00 ± 0.00</td><td>4.67 ± 0.58</td></tr><tr><td>4.00 ± 1.00</td><td>4.00 ± 1.00</td></tr><tr><td>4.67 ± 0.... |
fa6bcdd7bf3356915631ba4587c9aac44f7d3ed2da8b38888a90f3e58ae4ea8b.png | simple | <table><tr><td> </td><td>MQ2 Aspect ratio</td><td>HD magnet Aspect ratio</td><td>Difference</td></tr><tr><td>Top & Bottom</td><td>0.204</td><td>0.123</td><td>–40.7%</td></tr><tr><td>Middle</td><td>0.203</td><td>0.081</td><td>–60.9%</td></tr><tr><td>Left & Right</td><td>0.194</td><td>0.120</td><td>&#... | <table><tr><td></td><td>MQ2 Aspect ratio</td><td>HD magnet Aspect ratio</td><td>Difference</td></tr><tr><td>Top & Bottom</td><td>0.204</td><td>0.123</td><td>–40.7%</td></tr><tr><td>Middle</td><td>0.203</td><td>0.081</td><td>–60.9%</td></tr></table> | <table><tr><td></td><td>MQ2 Aspect ratio</td><td>HD magnet Aspect ratio</td><td>Difference</td></tr><tr><td>Left & Right</td><td>0.194</td><td>0.120</td><td>–38.1%</td></tr><tr><td>Corners</td><td>0.201</td><td>0.116</td><td>–42.2%</td></tr><tr><td>Average</td><td>0.200</td><td>0.110</td><td>–45.1%</td></tr></table> |
48469bab67567c8d0e258c4e06da97642c525afaeb7328753c7ebf5a67be7dd6.png | complex | <table><tr><td>Treatment</td><td colspan="2">Total episodes</td><td colspan="2">1st episode</td><td colspan="2">2nd and subsequent episodes</td></tr><tr><td></td><td></td><td></td><td>mild</td><td>severe</td><td>mild</td><td>severe</td></tr><tr><td>Total</td><td>781</td><td></td><td>575 (96%)</td><td>22 (4%)</td><td>17... | <table><tr><td>Treatment</td><td colspan="2">Total episodes</td><td colspan="2">1st episode</td><td colspan="2">2nd and subsequent episodes</td></tr><tr><td></td><td></td><td></td><td>mild</td><td>severe</td><td>mild</td><td>severe</td></tr><tr><td>Total</td><td>781</td><td></td><td>575 (96%)</td><td>22 (4%)</td><td>17... | <table><tr><td>Treatment</td><td colspan="2">Total episodes</td><td colspan="2">1st episode</td><td colspan="2">2nd and subsequent episodes</td></tr><tr><td>native antidiarrhoeal drugs</td><td>2</td><td>%</td><td>%)</td><td>(5%)</td><td></td><td>0</td></tr><tr><td>Visited physician for diarrhoea</td><td>25</td><td>3%</... |
845931b25288705d00bbfd8bc0847dfe023b65341f1169108fd91fc92c32416f.png | complex | <table><tr><td></td><td>ICD Codes/Conditions</td><td>Frequency of Admissions</td><td>Percentage of Total Admissions</td></tr><tr><td colspan="4">Top Reasons for Primary Admission (<1 YEAR)</td></tr><tr><td> Lower respiratory tract infection</td><td></td><td>44</td><td>40.8</td></tr><tr><td></td><td>Lower respiratory... | <table><tr><td></td><td>ICD Codes/Conditions</td><td>Frequency of Admissions</td><td>Percentage of Total Admissions</td></tr></table> | <table><tr><td colspan="4">Top Reasons for Primary Admission (<1 YEAR)</td></tr><tr><td>Lower respiratory tract infection</td><td></td><td>44</td><td>40.8</td></tr><tr><td></td><td>Lower respiratory tract infection (J22)</td><td>42</td><td></td></tr><tr><td></td><td>Bronchiolitis (J21.9)</td><td>2</td><td></td></tr><tr... |
af10a554a4fa0b6896e78e21ad1f5366908ce42ba701f3d0071900d82b906b3b.png | simple | <table><tr><td> </td><td>Val/Val n = 60</td><td>Met carriers n = 41</td></tr><tr><td>Age (mean ± SD) (years)</td><td>38.1 ± 8.5</td><td>39.7 ± 10.7</td></tr><tr><td>Gender, males n (%)</td><td>24 (40)</td><td>21 (51)</td></tr><tr><td>Smoking habit, n (%)</td><td>17 (28)</td><td>12 (29)</td></tr></table> | <table><tr><td></td><td>Val/Val n = 60</td></tr><tr><td>Age (mean ± SD) (years)</td><td>38.1 ± 8.5</td></tr><tr><td>Gender, males n (%)</td><td>24 (40)</td></tr><tr><td>Smoking habit, n (%)</td><td>17 (28)</td></tr></table> | <table><tr><td>Met carriers n = 41</td></tr><tr><td>39.7 ± 10.7</td></tr><tr><td>21 (51)</td></tr><tr><td>12 (29)</td></tr></table> |
7b838d97c889a09bf48d64b33f86dcb0b131d36378aa88f3aecb68b4fbed27ce.png | complex | <table><tr><td rowspan="2">Number of metabolic syndrome components (number of girls/boys)</td><td colspan="2">HOMA-IR</td></tr><tr><td>Girls</td><td>Boys</td></tr><tr><td>0 (468/301 girls/boys)</td><td>2.12 (1.53; 2.84)</td><td>1.90 (1.42; 2.61)</td></tr><tr><td>1 ( 381/359 girls/boys)</td><td>2.55 (1.80; 3.45)</td><td... | <table><tr><td rowspan="2">Number of metabolic syndrome components (number of girls/boys)</td><td colspan="2">HOMA-IR</td></tr><tr><td>Girls</td><td>Boys</td></tr><tr><td>0 (468/301 girls/boys)</td><td>2.12 (1.53; 2.84)</td><td>1.90 (1.42; 2.61)</td></tr></table> | <table><tr><td>1 ( 381/359 girls/boys)</td><td>2.55 (1.80; 3.45)</td><td>2.28 (1.65; 3.11)</td></tr><tr><td>2 (174/168 girls/boys)</td><td>2.85 (2.09; 4.37)</td><td>3.19 (2.20; 5.03)</td></tr><tr><td>3 (54/76 girls/boys)</td><td>3.60 (2.56; 5.69)</td><td>4.44 (2.88; 6.25)</td></tr><tr><td>4 (4/29 girls/boys)</td><td>5.... |
932d85f3f4228171e21147fe0f414ec3e9d1bb655c73f591d69510519b01ae6b.png | complex | <table><tr><td>`Parameter</td><td>Time</td><td>Placebo (SCG-P) (n = 14)</td><td>Cromolyn 20 mg (SCG-20) (n = 14)</td><td>Cromolyn 40 mg (SCG-40) (n = 12)</td><td>p-value </td></tr><tr><td rowspan="4">FEV1 </td><td>Baseline</td><td>60.07 ± 3.29 </td><td>57.33 ± 3.54 </td><td>67.49 ±2.04 </td><td>NS</td></... | <table><tr><td>`Parameter</td></tr><tr><td rowspan="4">FEV1</td></tr><tr></tr><tr></tr><tr></tr><tr><td rowspan="4">FVC</td></tr><tr></tr><tr></tr><tr></tr><tr><td rowspan="4">PEF</td></tr><tr></tr><tr></tr><tr></tr><tr><td rowspan="4">MEF75%</td></tr><tr></tr><tr></tr><tr></tr><tr><td rowspan="4">MEF50%</td></tr><tr><... | <table><tr><td>Time</td><td>Placebo (SCG-P) (n = 14)</td><td>Cromolyn 20 mg (SCG-20) (n = 14)</td><td>Cromolyn 40 mg (SCG-40) (n = 12)</td><td>p-value</td></tr><tr><td>Baseline</td><td>60.07 ± 3.29</td><td>57.33 ± 3.54</td><td>67.49 ±2.04</td><td>NS</td></tr><tr><td>15 min</td><td>60.56 ± 3.29</td><td>58.85 ± 3.22</td>... |
5a7ff5105e8811464b75cfc3a9e4c700c7785e7ec2aeda0b8ce931c415508e6d.png | simple | <table><tr><td>Fold Change</td><td>Method</td><td>Accuracy %</td><td>Sensitivity %</td><td>PPV %</td><td>F-Score %</td></tr><tr><td></td><td>FishersTotal</td><td>70.41%</td><td>70.79%</td><td>91.24%</td><td>79.72%</td></tr><tr><td></td><td>FishersHousekeeping</td><td>65.60%</td><td>65.22%</td><td>95.05%</td><td>77.36%<... | <table><tr><td>Fold Change</td><td>Method</td><td>Accuracy %</td><td>Sensitivity %</td><td>PPV %</td><td>F-Score %</td></tr><tr><td></td><td>FishersTotal</td><td>70.41%</td><td>70.79%</td><td>91.24%</td><td>79.72%</td></tr><tr><td></td><td>FishersHousekeeping</td><td>65.60%</td><td>65.22%</td><td>95.05%</td><td>77.36%<... | <table><tr><td>IsoDE-All</td><td>81.20%</td><td>86.74%</td><td>83.07%</td><td>84.87%</td></tr></table> |
37c3339a89087709d3cd8de91aaf754d17d12d3a25b61ef2ac2d2fd090997bec.png | complex | <table><tr><td>Application</td><td colspan="3">Method (Sample Size)</td></tr><tr><td></td><td>MOAT (240)</td><td>Importance Measures (400)</td><td>VBD (2000)</td></tr><tr><td>Watershed</td><td>15 681</td><td>27 078</td><td>150 890</td></tr><tr><td>Level Set</td><td>6,825</td><td>22 696</td><td>211 912</td></tr></table> | <table><tr><td>Application</td><td colspan="3">Method (Sample Size)</td></tr><tr><td></td><td>MOAT (240)</td><td>Importance Measures (400)</td><td>VBD (2000)</td></tr><tr><td>Watershed</td><td>15 681</td><td>27 078</td><td>150 890</td></tr></table> | <table><tr><td>Level Set</td><td>6,825</td><td>22 696</td><td>211 912</td></tr></table> |
65e732c14ed1bf687837592146e01f5c70ff6c80afcdaded22daccf26e3b2e8c.png | complex | <table><tr><td>Variable</td><td>OR</td><td>CI</td><td>p-value</td></tr><tr><td>Age</td><td>1.15</td><td>0.86-1.54</td><td>0.53</td></tr><tr><td>Gender</td><td></td><td></td><td rowspan="3">0.07</td></tr><tr><td>Male</td><td>Ref</td><td></td></tr><tr><td>Female</td><td>0.28</td><td>——0.07-1.13</td></tr><tr><... | <table><tr><td>Variable</td><td>OR</td><td>CI</td><td>p-value</td></tr><tr><td>Age</td><td>1.15</td><td>0.86-1.54</td><td>0.53</td></tr><tr><td>Gender</td><td></td><td></td><td rowspan="3">0.07</td></tr><tr><td>Male</td><td>Ref</td><td></td></tr><tr><td>Female</td><td>0.28</td><td>——0.07-1.13</td></tr><tr><td>Marital s... | <table><tr><td>es</td><td></td><td></td><td rowspan="2">0.03</td></tr><tr><td>No</td><td>0.33</td><td>——0.12-0.89</td></tr><tr><td>Activity involvement:</td><td></td><td></td><td></td></tr><tr><td>Read fiction literature for entertainment</td><td>1.46</td><td>1.10-1.99</td><td>0.02</td></tr><tr><td>Go to parties, café... |
03292b05a9b9f9692e74cafe3b2104a2111715a1c8dea64cc76b7b4f63104d96.png | complex | <table><tr><td>Variable</td><td>Description</td><td>Type</td><td>Values</td><td>Frequency</td><td>Percent</td></tr><tr><td rowspan="3">High Blood Pressure (mmHg) Diastolic Systolic </td><td rowspan="3">Blood pressure measured around the arm above the elbow; it detects the amount of pressure in the blood flowing in the ... | <table><tr><td>Variable</td><td>Description</td><td>Type</td><td>Values</td><td>Frequency</td><td>Percent</td></tr><tr><td rowspan="3">High Blood Pressure (mmHg) Diastolic Systolic</td><td rowspan="3">Blood pressure measured around the arm above the elbow; it detects the amount of pressure in the blood flowing in the v... | <table><tr><td>BMI (weight in kg/squared height in meters)</td><td>Calculated based on calibrated measurements performed by school nurse</td><td>Continuous Ordinal</td><td>4 ≥ 30.0 Obese</td><td>117</td><td>27.0</td></tr><tr><td rowspan="2">Tobacco Use</td><td rowspan="2">Do you smoke</td><td rowspan="2">Dichotomous</t... |
1fb2a296309c99de66cb9ab5bb836597e6286987bb55d722f8f65a35b55cb4bd.png | complex | <table><tr><td>Variables</td><td>Baseline</td><td>Post-treatment</td></tr><tr><td colspan="3">OHRQoL scores</td></tr><tr><td> Total score</td><td>16.67 (12.10)</td><td>7.05 (7.16) **</td></tr><tr><td> Functional limitation</td><td>1.83 (2.21)</td><td>1.08 (1.48) **</td></tr><tr><td> Physical pain</td><td>3.55 (1.81)</t... | <table><tr><td>Variables</td><td>Baseline</td><td>Post-treatment</td></tr><tr><td colspan="3">OHRQoL scores</td></tr><tr><td>Total score</td><td>16.67 (12.10)</td><td>7.05 (7.16) **</td></tr><tr><td>Functional limitation</td><td>1.83 (2.21)</td><td>1.08 (1.48) **</td></tr><tr><td>Physical pain</td><td>3.55 (1.81)</td><... | <table><tr><td>No. of teeth (n)</td><td>26.96 (2.24)</td><td>26.39 (2.71) **</td></tr><tr><td>PD (mm)</td><td>3.00 (0.75)</td><td>2.53 (0.65) **</td></tr><tr><td>CAL (mm)</td><td>2.66 (1.46)</td><td>2.50 (1.47) *</td></tr><tr><td>FMBS (%)</td><td>35.07 (23.52)</td><td>19.99 (16.13) **</td></tr><tr><td>PD ≥ 4 mm (%)</td... |
308c65710b4fa995af627ec51c10ec1124f043b17686f222c48c97b761f2a7ed.png | simple | <table><tr><td>Sample name</td><td>Silicon-rich concentration(volume percentage v%)</td><td>Sample structure/thickness (nm)</td></tr><tr><td>SRC80</td><td>80</td><td>Single layer/approximately 600</td></tr><tr><td>SRC70</td><td>70</td><td>Single layer/approximately 600</td></tr><tr><td>SRC60</td><td>60</td><td>Single l... | <table><tr><td>Sample name</td><td>Silicon-rich concentration(volume percentage v%)</td><td>Sample structure/thickness (nm)</td></tr><tr><td>SRC80</td><td>80</td><td>Single layer/approximately 600</td></tr><tr><td>SRC70</td><td>70</td><td>Single layer/approximately 600</td></tr><tr><td>SRC6</td><td>60</td><td>Single la... | <table><tr><td>0</td><td></td><td>y 600</td></tr><tr><td>SRC50</td><td>50</td><td>Single layer/approximately 600</td></tr><tr><td>SiC</td><td>0</td><td>Single layer/approximately 600</td></tr></table> |
26fbb4e71faf4bc811cc943ddadca07f6ada3da00882b1e13eaf387e4bdd6f43.png | complex | <table><tr><td> </td><td colspan="3">Control subjects</td><td colspan="3">STAMPEDE subjects</td><td colspan="3">Subset of STAMPEDE subjects</td><td>STAMPEDE vs CONTROLS</td><td>STAMPEDE subset vs controls</td></tr><tr><td>Entrez ID</td><td>Mean</td><td>ST DEV</td><td>CV, %</td><td>Mean</td><td>ST DEV</td><td>CV, %</td>... | <table><tr><td></td><td colspan="3">Control subjects</td><td colspan="3">STAMPEDE subjects</td></tr><tr><td>Entrez ID</td><td>Mean</td><td>ST DEV</td><td>CV, %</td><td>Mean</td><td>ST DEV</td><td>CV, %</td></tr><tr><td>A1AG1</td><td>18.69</td><td>0.40</td><td>2.1</td><td>19.49</td><td>0.52</td><td>2.7</td></tr><tr><td>... | <table><tr><td colspan="3">Subset of STAMPEDE subjects</td><td>STAMPEDE vs CONTROLS</td><td>STAMPEDE subset vs controls</td></tr><tr><td>Mean</td><td>ST DEV</td><td>CV, %</td><td>p value</td><td>p value</td></tr><tr><td>19.98</td><td>0.44</td><td>2.2</td><td>0.00055429</td><td>5.95509E-07</td></tr><tr><td>19.52</td><td... |
d8fec0b1beb7274784ac007a44e3f5b58d26ce472e978665965b67836f1cef69.png | complex | <table><tr><td>Patients</td><td>Sex</td><td>Age</td><td>pH juice</td><td>Sample</td><td>Log10 CFU/g or ml</td><td><i>Bifidobacteriaceae</i> species</td></tr><tr><td colspan="6">AAG groups (2 of 10 patients)</td><td></td></tr><tr><td>1</td><td>F</td><td>60</td><td>7.84</td><td>Juice</td><td>5.30</td><td>Sca.</td></tr><t... | <table><tr><td>Patients</td><td>Sex</td><td>Age</td><td>pH juice</td><td>Sample</td><td>Log10 CFU/g or ml</td><td>Bifidobacteriaceae species</td></tr><tr><td colspan="6">AAG groups (2 of 10 patients)</td><td></td></tr><tr><td>1</td><td>F</td><td>60</td><td>7.84</td><td>Juice</td><td>5.30</td><td>Sca.</td></tr><tr><td><... | <table><tr><td>6</td><td>F</td><td>44</td><td>7.41</td><td>Juice</td><td>5.30</td><td>Bif.d.;Par.;Sca.</td></tr><tr><td></td><td></td><td></td><td></td><td>Antrum</td><td>4.07</td><td>Par.</td></tr><tr><td></td><td></td><td></td><td></td><td>Corpus</td><td>4.00</td><td>Par.</td></tr><tr><td>7</td><td>F</td><td>70</td><... |
acd376b5ce65bbaf4d8d531c60564a43acfd180e914746c45aa01c08fd8f0553.png | complex | <table><tr><td>Date, meal, food item</td><td colspan="3">Exposed</td><td colspan="3">Not exposed</td><td>RR</td><td>95% CI</td><td>AF</td></tr><tr><td></td><td>ill</td><td>not ill</td><td>AR (%)</td><td>ill</td><td>not ill</td><td>AR (%)</td><td></td><td></td><td></td></tr><tr><td colspan="10">Cohort from units 1 and 9... | <table><tr><td>Date, meal, food item</td><td colspan="3">Exposed</td><td colspan="3">Not exposed</td><td>RR</td><td>95% CI</td><td>AF</td></tr><tr><td></td><td>ill</td><td>not ill</td><td>AR (%)</td><td>ill</td><td>not ill</td><td>AR (%)</td><td></td><td></td><td></td></tr><tr><td colspan="10">Cohort from units 1 and 9... | <table><tr><td>Date, meal, food item</td><td colspan="3">Exposed</td><td colspan="3">Not exposed</td><td>RR</td><td>95% CI</td><td>AF</td></tr><tr><td></td><td>ill</td><td>not ill</td><td>AR (%)</td><td>ill</td><td>not ill</td><td>AR (%)</td><td></td><td></td><td></td></tr><tr><td>, lunch, "light meal"</td><td></td><td... |
53fdcbf708a726bcb86b79c01fa59b7746f2ed8ebcca5791874965bee2f79307.png | simple | <table><tr><td>No.</td><td>MCs tot <sup>a,b</sup></td><td>ANA-a <sup>a</sup></td><td>ANA-a</td><td>DH-ANA-a <sup>c</sup></td><td>E-ANA-a <sup>c</sup></td><td>MC-RR</td><td>MC-YR</td><td>MC-LR</td><td>MC-LA</td><td>MC-LY</td><td>MC-LW</td><td>MC-LF</td><td>CYN</td><td>STX</td><td>BMAA</td></tr><tr><td>1</td><td>ND</td><... | <table><tr><td>No.</td><td>MCs tot a,b</td></tr><tr><td>1</td><td>ND</td></tr><tr><td>2</td><td>ND</td></tr><tr><td>3</td><td>ND</td></tr><tr><td>4</td><td>ND</td></tr><tr><td>5</td><td>ND</td></tr><tr><td>6</td><td>ND</td></tr><tr><td>7</td><td>ND</td></tr><tr><td>8</td><td>0.25 (10)</td></tr><tr><td>9</td><td>ND</td>... | <table><tr><td>ANA-a a</td><td>ANA-a</td><td>DH-ANA-a c</td><td>E-ANA-a c</td><td>MC-RR</td><td>MC-YR</td><td>MC-LR</td><td>MC-LA</td><td>MC-LY</td><td>MC-LW</td><td>MC-LF</td><td>CYN</td><td>STX</td><td>BMAA</td></tr><tr><td>ND</td><td>ND</td><td>ND</td><td>ND</td><td>ND</td><td>ND</td><td>ND</td><td>ND</td><td>ND</td... |
a21874207b0bc0f2b25cc7e1b69f13bfce8ef5247e49c1df08f063a3f8223909.png | simple | <table><tr><td>Cr</td><td>Co</td><td>Mo</td><td>Al</td><td>Ti</td><td>C</td><td>B</td><td>Ni</td></tr><tr><td>19.5</td><td>13.5</td><td>4.3</td><td>1.3</td><td>3</td><td>0.08</td><td>0.006</td><td>Bal</td></tr></table> | <table><tr><td>Cr</td><td>Co</td><td>Mo</td><td>Al</td><td>Ti</td><td>C</td><td>B</td><td>Ni</td></tr></table> | <table><tr><td>19.5</td><td>13.5</td><td>4.3</td><td>1.3</td><td>3</td><td>0.08</td><td>0.006</td><td>Bal</td></tr></table> |
92f136fd51e7db2261a1dfff264b92ef8a3cc91246bf4696bf14bc0c5f245e67.png | simple | <table><tr><td>Name</td><td>Thermal Treatment</td><td>Surface * (m<sup>2</sup>/g)</td><td>D90 ** (μm)</td><td>D50 ** (μm)</td><td>D10 ** (μm)</td><td>S (%)</td><td>N (%)</td><td>Fe (%)</td><td>Si (%)</td><td>Ni (%)</td><td>P (ppm)</td><td>B (ppm)</td></tr><tr><td>CNF A</td><td>no</td><td>103</td><td>2.2<... | <table><tr><td>Name</td><td>Thermal Treatment</td><td>Surface * (m2/g)</td><td>D90 ** (μm)</td><td>D50 ** (μm)</td><td>D10 ** (μm)</td><td>S (%)</td><td>N (%)</td><td>Fe (%)</td><td>Si (%)</td><td>Ni (%)</td><td>P (ppm)</td><td>B (ppm)</td></tr><tr><td>CNF A</td><td>no</td><td>103</td><td>2.2</td><td>1.6</td><td>0.7</t... | <table><tr><td>CNF B</td><td>yes</td><td>61</td><td>2.2</td><td>1.9</td><td>1.6</td><td><0.010</td><td>0.016</td><td>0.023</td><td>0.012</td><td>0.070</td><td>3.8</td><td>2.0</td></tr><tr><td>CNF C</td><td>no</td><td>124</td><td>2.6</td><td>1.7</td><td>0.8</td><td>0.095</td><td>0.037</td><td>0.148</td><td>0.056</td><td... |
effe759ac96d5a05967765a094d2878374b1f3dd511e7fe0488cd1aa58c58984.png | complex | <table><tr><td colspan="2">Course level</td></tr><tr><td>Level 1</td><td>Text, images, audio, simple interactivities for content presentation. Template layout</td></tr><tr><td>Level 2</td><td>Level 1+video and simple animations. Fewer pages with template layout</td></tr><tr><td>Level 3</td><td>Complex animation, high-f... | <table><tr><td colspan="2">Course level</td></tr><tr><td>Level 1</td><td>Text, images, audio, simple interactivities for content presentation. Template layout</td></tr><tr><td>Level 2</td><td>Level 1+video and simple animations. Fewer pages with template layout</td></tr></table> | <table><tr><td>Level 3</td><td>Complex animation, high-fidelity/3D graphics, complex multilevel, and multivariable interaction</td></tr></table> |
247f146bbbde8386577557aaed56fcb371dc156fbbb90fcc9f9c7bf44e271474.png | complex | <table><tr><td> </td><td colspan="2">Underweight (<i>n</i> = 39)</td><td colspan="2">Normal (<i>n</i> = 280)</td><td colspan="2">Overweight (<i>n</i> = 121)</td><td colspan="2">Obese (<i>n</i> = 304)</td></tr><tr><td> </td><td>Estimates (SE)</td><td><i>p</i> value</td><td>Estimates (SE)</td><td><i>p</i> value</td><td>E... | <table><tr><td></td><td colspan="2">Underweight (n = 39)</td><td colspan="2">Normal (n = 280)</td><td colspan="2">Overweight (n = 121)</td><td>Obese (n = 304)</td></tr><tr><td></td><td>Estimates (SE)</td><td>p value</td><td>Estimates (SE)</td><td>p value</td><td>Estimates (SE)</td><td>p value</td><td>Estimates (SE)</td... | <table><tr><td>Obese (n = 304)</td></tr><tr><td>p value</td></tr><tr><td>0.84</td></tr><tr><td>0.34</td></tr><tr><td>0.54</td></tr><tr><td><0.0001∗</td></tr><tr><td>0.01∗</td></tr><tr><td>0.01∗</td></tr><tr><td><0.0001a,∗</td></tr></table> |
bad037f3ba0f02119f4fe4a40135b3f851a2f9d4d802c398269859d8328f7241.png | simple | <table><tr><td>Grade</td><td>Forequarter%</td><td>Ribs/Flank%</td><td>Rump/Round%</td><td>Loin%</td><td>T. Coxae (hip)%</td><td>T. Ischiadicum (rear)%</td><td>Total%</td></tr><tr><td>1</td><td>12.2</td><td>7.9</td><td>8.3</td><td>5.5</td><td>20.0</td><td>14.9</td><td>68.7</td></tr><tr><td>2</td><td>10.2</td><td>6.3</td... | <table><tr><td>Grade</td><td>Forequarter%</td><td>Ribs/Flank%</td><td>Rump/Round%</td><td>Loin%</td><td>T. Coxae (hip)%</td><td>T. Ischiadicum (rear)%</td><td>Total%</td></tr></table> | <table><tr><td>1</td><td>12.2</td><td>7.9</td><td>8.3</td><td>5.5</td><td>20.0</td><td>14.9</td><td>68.7</td></tr><tr><td>2</td><td>10.2</td><td>6.3</td><td>1.9</td><td>1.3</td><td>9.3</td><td>2.4</td><td>31.3</td></tr><tr><td>Total</td><td>22.4</td><td>14.1</td><td>10.1</td><td>6.8</td><td>29.3</td><td>17.3</td><td>10... |
9e14ef36dfd87fb4ed689ac0b80037a988968680af98d631d2916b30470e2851.png | simple | <table><tr><td>Characteristics</td><td>HR<sup>*</sup> (95% CI)</td><td><i>P</i></td></tr><tr><td><i>EGFR CNG</i></td><td>2.31 (1.44-3.69)</td><td>0.001</td></tr><tr><td><i>HER2 CNG</i></td><td>1.21 (0.75-1.92)</td><td>0.44</td></tr><tr><td><i>HER3 CNG</i></td><td>1.36 (0.85-2.15)</td><td>0.19</td></tr><tr><td><i>HER4 C... | <table><tr><td>Characteristics</td><td>HR* (95% CI)</td><td>P</td></tr><tr><td>EGFR CNG</td><td>2.31 (1.44-3.69)</td><td>0.001</td></tr><tr><td>HER2 CNG</td><td>1.21 (0.75-1.92)</td><td>0.44</td></tr><tr><td>HER3 CNG</td><td>1.36 (0.85-2.15)</td><td>0.19</td></tr><tr><td>HER4 CNG</td><td>1.29 (0.82-2.03)</td><td>0.28</... | <table><tr><td>Characteristics</td><td>HR* (95% CI)</td><td>P</td></tr><tr><td>KPS score3</td><td>1.38 (0.86-2.21)</td><td>0.18</td></tr><tr><td>Recurrence</td><td>44.86 (6.16-327.00)</td><td><0.001</td></tr><tr><td>Radiotherapy</td><td>0.47 (0.30-0.75)</td><td><0.001</td></tr><tr><td>Chemotherapy</td><td>1.45 (0.92-2.... |
fbeb81d6f940fc1a1e96e21485531f36fa779ab3900f55ed8c70019b17431f70.png | complex | <table><tr><td rowspan="2">Gene</td><td rowspan="2">Location</td><td colspan="5">Length (bp)</td></tr><tr><td>Exon I</td><td>Intron I</td><td>Exon II</td><td>Intron II</td><td>Exon III</td></tr><tr><td><i>rps12</i></td><td>LSC</td><td>114</td><td>-</td><td>270</td><td></td><td></td></tr><tr><td><i>ndhB</i></td><td>LSC<... | <table><tr><td rowspan="2">Gene</td><td rowspan="2">Location</td><td colspan="5">Length (bp)</td></tr><tr><td>Exon I</td><td>Intron I</td><td>Exon II</td><td>Intron II</td><td>Exon III</td></tr><tr><td>rps12</td><td>LSC</td><td>114</td><td>-</td><td>270</td><td></td><td></td></tr><tr><td>ndhB</td><td>LSC</td><td>729</t... | <table><tr><td>trnA-UGC</td><td>IR</td><td>38</td><td>763</td><td>35</td><td></td><td></td></tr></table> |
e6d9cd80b841ded256e444a8b47a8dd5c9fd99bfb83dc7b95d33616923ad75e8.png | complex | <table><tr><td> </td><td colspan="2"><i>“At”</i></td><td colspan="2"><i>“From”</i></td><td> </td><td> </td></tr><tr><td>Method</td><td>M</td><td>SD</td><td>M</td><td>SD</td><td>t</td><td>P</td></tr><tr><td>Persuasive Communication</td><td>4.85</td><td>0.37</td><td>4.15</td><td>1.14</td><td>2.77<... | <table><tr><td></td><td colspan="2">“At”</td><td colspan="2">“From”</td><td></td><td></td></tr><tr><td>Method</td><td>M</td><td>SD</td><td>M</td><td>SD</td><td>t</td><td>P</td></tr><tr><td>Persuasive Communication</td><td>4.85</td><td>0.37</td><td>4.15</td><td>1.14</td><td>2.77</td><td>.01</td></tr><tr><td>Tailoring</t... | <table><tr><td></td><td colspan="2">“At”</td><td colspan="2">“From”</td><td></td><td></td></tr><tr><td>Method</td><td>M</td><td>SD</td><td>M</td><td>SD</td><td>t</td><td>P</td></tr><tr><td>Team Building</td><td>3.70</td><td>1.13</td><td>3.65</td><td>1.31</td><td>0.16</td><td>.87</td></tr><tr><td>Structural Redesign</td... |
374e5a20b3c9ee9092cfbe0ebcf122218feb1d1d884d329671a01dd00ba538b1.png | simple | <table><tr><td><i>PML isoform</i></td><td><i>Wild type</i></td><td><i>Nuclear import-defective mutant</i></td></tr><tr><td>PML I</td><td>PML NBs</td><td>Early endosomes</td></tr><tr><td>PML II</td><td>Nuclear periphery</td><td>Nuclear periphery</td></tr><tr><td>PML III</td><td>PML NBs</td><td>Late endosomes/lysosomes</... | <table><tr><td>PML isoform</td><td>Wild type</td><td>Nuclear import-defective mutant</td></tr><tr><td>PML I</td><td>PML NBs</td><td>Early endosomes</td></tr><tr><td>PML II</td><td>Nuclear periphery</td><td>Nuclear periphery</td></tr><tr><td>PML III</td><td>PML NBs</td><td>Late endosomes/lysosomes</td></tr><tr><td>PML I... | <table><tr><td>PML isoform</td><td>Wild type</td><td>Nuclear import-defective mutant</td></tr><tr><td>PML V</td><td>PML NBs</td><td>Late endosomes/lysosomes</td></tr><tr><td>PML VII</td><td>Late endosomes/lysosomes</td><td>Not applicable</td></tr></table> |
52fd0bae8df0d1b362e6edb3c9071a00a35ef5a72695d358144820d3ad68434c.png | simple | <table><tr><td>Species</td><td>m</td><td>M</td><td>N-M</td><td>n</td><td>Adjusted p-value</td></tr><tr><td><i>Dengue virus</i></td><td>14</td><td>41</td><td>55016</td><td>550</td><td>0.00E+00</td></tr><tr><td><i>Deer tick virus</i></td><td>5</td><td>10</td><td>55047</td><td>550</td><td>8.20E-06</td></tr><tr><td><i>Myco... | <table><tr><td>Species</td><td>m</td><td>M</td><td>N-M</td><td>n</td><td>Adjusted p-value</td></tr><tr><td>Dengue virus</td><td>14</td><td>41</td><td>55016</td><td>550</td><td>0.00E+00</td></tr><tr><td>Deer tick virus</td><td>5</td><td>10</td><td>55047</td><td>550</td><td>8.20E-06</td></tr><tr><td>Mycoplasma</td><td>4<... | <table><tr><td>A-2 plaque virus</td><td>2</td><td>8</td><td>55049</td><td>550</td><td>0.6017</td></tr><tr><td>Phytomyza</td><td>5</td><td>100</td><td>54957</td><td>550</td><td>0.6325</td></tr><tr><td>Orf virus</td><td>6</td><td>150</td><td>54907</td><td>550</td><td>0.6859</td></tr><tr><td>Brevibacterium</td><td>3</td><... |
d6aade23d4eacb0953aedb701f2050b2b7df28f1f0555340b41e12c55289a1a1.png | simple | <table><tr><td>Gene</td><td>Complex</td><td>SNP</td><td>Major/minor allele</td><td>Location</td><td>MAF</td></tr><tr><td>NDUFS2</td><td>I</td><td>rs33941127</td><td>C/T</td><td>Promoter</td><td>T - 0.21</td></tr><tr><td>NDUFS2</td><td>I</td><td>rs3813623</td><td>G/T</td><td>5′-UTR</td><td>T - 0.15</td></tr><tr><t... | <table><tr><td>Gene</td><td>Complex</td><td>SNP</td><td>Major/minor allele</td><td>Location</td><td>MAF</td></tr><tr><td>NDUFS2</td><td>I</td><td>rs33941127</td><td>C/T</td><td>Promoter</td><td>T - 0.21</td></tr><tr><td>NDUFS2</td><td>I</td><td>rs3813623</td><td>G/T</td><td>5′-UTR</td><td>T - 0.15</td></tr><tr><td>NDUF... | <table><tr><td>ATP5C1</td><td>V</td><td>rs4655</td><td>T/C</td><td>3′-UTR</td><td>C - 0.36</td></tr><tr><td>GAPDH</td><td></td><td>rs7971637</td><td>C/T</td><td>Promoter</td><td>T - 0.19</td></tr><tr><td>GAPDH</td><td></td><td>rs1136666</td><td>C/G</td><td>5′-UTR</td><td>G - 0.26</td></tr><tr><td>HSPD1</td><td></td><td... |
1d478f15f76bfa2fcede7f7ce8cf063b45369af9863df11ca31e24a526914261.png | simple | <table><tr><td>MIGS ID</td><td>Property</td><td>Term</td></tr><tr><td>MIGS-31</td><td>Finishing quality</td><td>Finished</td></tr><tr><td>MIGS-28</td><td>Libraries used</td><td>Three genomic libraries:two Sanger libraries – 8 kb pMCL200 and fosmid pcc1FOSand one 454 pyrosequece standard library</td></tr><tr><td>M... | <table><tr><td>MIGS ID</td><td>Property</td><td>Term</td></tr><tr><td>MIGS-31</td><td>Finishing quality</td><td>Finished</td></tr><tr><td>MIGS-28</td><td>Libraries used</td><td>Three genomic libraries:two Sanger libraries – 8 kb pMCL200 and fosmid pcc1FOSand one 454 pyrosequece standard library</td></tr><tr><td>MIGS-29... | <table><tr><td>MIGS ID</td><td>Property</td><td>Term</td></tr><tr><td></td><td>INSDC ID</td><td>CP001874</td></tr><tr><td></td><td>Genbank Date of Release</td><td>May 17, 2010</td></tr><tr><td></td><td>GOLD ID</td><td>Gc01281</td></tr><tr><td></td><td>NCBI project ID</td><td>469371</td></tr><tr><td></td><td>Database: I... |
cbcefea2a06965db77a889b2601e7deda3f5c946b06bcea7a3ef6816fa418797.png | simple | <table><tr><td>Plot properties with increasing accelerator</td><td>Mechanistic conclusions</td></tr><tr><td>PAA saturates to 100%</td><td><i>d</i> is before or at <i>j</i></td></tr><tr><td>PAA does not saturate to 100%</td><td><i>d</i> is after <i>j</i></td></tr><tr><td>Saturated PAA less than 100%</td><td>1. Equilibri... | <table><tr><td>Plot properties with increasing accelerator</td></tr><tr><td>PAA saturates to 100%</td></tr><tr><td>PAA does not saturate to 100%</td></tr><tr><td>Saturated PAA less than 100%</td></tr><tr><td>Saturated PAA greater than 100%</td></tr><tr><td>PAA increases as linear-fractional function to maximum of 100%<... | <table><tr><td>Mechanistic conclusions</td></tr><tr><td>d is before or at j</td></tr><tr><td>d is after j</td></tr><tr><td>1. Equilibrium constant of antagonist at step d is less than that of agonist at step d and d is after j. Product is mostly derived from steps after d.2. Equilibrium constant of antagonist is greate... |
0c1d87969be7f778f4bdf3e8dc1f5c3ceeea739f9cd4efa745d14eb313bbe264.png | complex | <table><tr><td>Village HAT status</td><td>Intervention participation</td><td>Cattle sampled (<i>n</i>)</td><td>TBSL + (<i>n</i>)</td><td>% TBSL +</td><td>SRA + (<i>n</i>)</td><td>% SRA +</td><td>TV + (<i>n</i>)</td><td>% TV +</td><td>TC + (<i>n</i>)</td><td>% TC +</td></tr><tr><td rowspan="4">HAT + villages</td><td></t... | <table><tr><td>Village HAT status</td><td>Intervention participation</td><td>Cattle sampled (n)</td><td>TBSL + (n)</td><td>% TBSL +</td><td>SRA + (n)</td><td>% SRA +</td><td>TV + (n)</td><td>% TV +</td><td>TC + (n)</td><td>% TC +</td></tr><tr><td rowspan="4">HAT + villages</td><td></td><td>956</td><td>195</td><td>20.4<... | <table><tr><td>HAT - villages</td><td>No intervention</td><td>350</td><td>61</td><td>17.4</td><td>1</td><td>0.3</td><td>0</td><td>0</td><td>36</td><td>10.3</td></tr></table> |
b59f7d99fe9a926efd3af6baa1cefb42c7ce233ad152db9e1e1b379d3c4230c5.png | simple | <table><tr><td>Variables</td><td>Percentages (%) ± SD</td><td>Normal Range †</td><td>P value</td></tr><tr><td>Total Carbohydrates</td><td>47.8%* ± 1.70</td><td>55 - 65%</td><td>.000</td></tr><tr><td>Total Fat</td><td>35.6%* ± 1.66</td><td>25 - 35%</td><td>.000</td></tr><tr><td>Saturated Fat</td><td... | <table><tr><td>Variables</td><td>Percentages (%) ± SD</td><td>Normal Range †</td><td>P value</td></tr><tr><td>Total Carbohydrates</td><td>47.8%* ± 1.70</td><td>55 - 65%</td><td>.000</td></tr><tr><td>Total Fat</td><td>35.6%* ± 1.66</td><td>25 - 35%</td><td>.000</td></tr><tr><td>Saturated Fat</td><td>16.5%* ± .84</td><td... | <table><tr><td>Variables</td><td>Percentages (%) ± SD</td><td>Normal Range †</td><td>P value</td></tr><tr><td>urated Fat</td><td>4</td><td>5-7%</td><td>00</td></tr><tr><td>Total Protein</td><td>16.6%* ± .80</td><td>10 - 15%</td><td>.000</td></tr></table> |
1e3310f5af69cb82d03f31340ebbe281190cb6ed21e1dab9d2c8d3921d1ab77c.png | complex | <table><tr><td rowspan="2">Species</td><td colspan="2">Mondragón-Jacobo et al. [11]</td><td colspan="2">Griffith and Porter [13]</td><td colspan="2">This protocol</td></tr><tr><td>DNA yield (ng/μl)</td><td>OD ratio <sub>260.280</sub></td><td>DNA yield (ng/μl)</td><td>OD ratio <sub>260.280</sub></td><td>... | <table><tr><td rowspan="2">Species</td><td colspan="2">Mondragón-Jacobo et al. [11]</td></tr><tr><td>DNA yield (ng/μl)</td><td>OD ratio 260.280</td></tr><tr><td>1. Opuntia auberi Pfeiff.</td><td>256</td><td>1.4</td></tr><tr><td>2. Opuntia decumbens Salm-Dyck</td><td>35</td><td>1.7</td></tr><tr><td>3. Opuntia delafuent... | <table><tr><td colspan="2">Griffith and Porter [13]</td><td colspan="2">This protocol</td></tr><tr><td>DNA yield (ng/μl)</td><td>OD ratio 260.280</td><td>DNA yield (ng/μl)</td><td>OD ratio 260.280</td></tr><tr><td>423</td><td>1.7</td><td>1600</td><td>1.9</td></tr><tr><td>30</td><td>1.9</td><td>2930</td><td>1.9</td></tr... |
2e7e4c103a829f9d600519ea25840e75582149b50a026af6429e965d6303a3ab.png | simple | <table><tr><td>Variables</td><td>2009–2010 Pandemic (<i>n</i> = 16)</td><td>2012–2016 Postpandemic (<i>n</i> = 60)</td><td><i>p</i> value</td></tr><tr><td>Male sex</td><td>8 (50)</td><td>42 (70)</td><td>0.15</td></tr><tr><td>Age, years</td><td>43 (32–53)</td><td>60 (50–65)</td><td>< 0.001</td... | <table><tr><td>Variables</td><td>2009–2010 Pandemic (n = 16)</td><td>2012–2016 Postpandemic (n = 60)</td><td>p value</td></tr><tr><td>Male sex</td><td>8 (50)</td><td>42 (70)</td><td>0.15</td></tr><tr><td>Age, years</td><td>43 (32–53)</td><td>60 (50–65)</td><td>< 0.001</td></tr><tr><td>BMI</td><td>29.7 (24.0–36.1)</td><... | <table><tr><td>Malignancy or immuno- suppressive medicationa</td><td>1 (6.3)</td><td>9 (15.0)</td><td>0.7</td></tr><tr><td>Epilepsy or other neurological disease</td><td>6 (37.5)</td><td>5 (8.3)</td><td>0.009</td></tr><tr><td>APACHE II score on admission</td><td>14 (10–17)</td><td>17 (13–22)</td><td>0.002</td></tr><tr>... |
b91e8ed59bbf85d60f24f1e161fcafc0e24c8c58adfa369d41820bee2fc08612.png | simple | <table><tr><td>OverallAge range</td><td>Transported patients/population</td><td>Transport rate(per 1000/year)</td><td>Rate ratio (95% CI)</td></tr><tr><td>85–99</td><td>59 570/237 873</td><td>250</td><td>reference</td></tr><tr><td>65–84</td><td>185 871/2 055 439</td><td>90</td><td>2.78 (2.17–3.58)</td... | <table><tr><td>OverallAge range</td><td>Transported patients/population</td><td>Transport rate(per 1000/year)</td><td>Rate ratio (95% CI)</td></tr><tr><td>85–99</td><td>59 570/237 873</td><td>250</td><td>reference</td></tr><tr><td>65–84</td><td>185 871/2 055 439</td><td>90</td><td>2.78 (2.17–3.58)</td></tr><tr><td>45–6... | <table><tr><td>OverallAge range</td><td>Transported patients/population</td><td>Transport rate(per 1000/year)</td><td>Rate ratio (95% CI)</td></tr><tr><td>85–99</td><td>21 151/72 432</td><td>292</td><td>reference</td></tr><tr><td>65–84</td><td>95 700/918 229</td><td>104</td><td>2.81 (2.24–3.55)</td></tr><tr><td>45–64</... |
3273caa1cb3cd550d3f8aafddbf5cd13f1653a91c77ce8f74be7595606650341.png | simple | <table><tr><td></td><td>Women of reproductive age (20–49 years)</td><td>Men (20–59 years)</td><td>Adolescent girls (15–19 years)</td><td>Adolescent boys (15–19 years)</td><td>Caregivers/family members</td><td>Total</td></tr><tr><td>Kenya</td><td>41</td><td>23</td><td>20</td><td>11</td><td>17</td... | <table><tr><td></td></tr><tr><td>Kenya</td></tr><tr><td>Nepal</td></tr><tr><td>Uganda</td></tr><tr><td>Total</td></tr></table> | <table><tr><td>Women of reproductive age (20–49 years)</td><td>Men (20–59 years)</td><td>Adolescent girls (15–19 years)</td><td>Adolescent boys (15–19 years)</td><td>Caregivers/family members</td><td>Total</td></tr><tr><td>41</td><td>23</td><td>20</td><td>11</td><td>17</td><td>112</td></tr><tr><td>40</td><td>29</td><td... |
f366d85031f859fae3b0c8673e40aafdf475da2e4a04bf33380b844ecbbff832.png | complex | <table><tr><td>Study</td><td>Penetration</td><td>Genital contact</td><td>Exposure of genitals to child</td><td>Attempted penetration</td><td>Exploitation: prostitution or pornography</td></tr><tr><td colspan="6">TYPE OF ABUSE</td></tr><tr><td>NIS-1</td><td>0.3/1,000</td><td>0.2/1,000</td><td>0.1/1,000</td></tr><tr><td>... | <table><tr><td>Study</td><td>Penetration</td><td>Genital contact</td><td>Exposure of genitals to child</td><td>Attempted penetration</td><td>Exploitation: prostitution or pornography</td></tr><tr><td colspan="6">TYPE OF ABUSE</td></tr><tr><td>NIS-1</td><td>0.3/1,000</td><td>0.2/1,000</td><td>0.1/1,000</td><td rowspan="... | <table><tr><td>Study</td><td>Penetration</td><td>Genital contact</td><td>Exposure of genitals to child</td><td>Attempted penetration</td><td>Exploitation: prostitution or pornography</td></tr><tr><td>Finkelhor et al. (2005)</td><td>4/1,000</td><td>32/1,000</td><td>4/1,000</td><td>18/1,000</td><td></td></tr></table> |
9d5bcaa81496e68ff6d16509681ba3b6ae977a8053434c929991aa99c0bcc706.png | simple | <table><tr><td>Tissue</td><td>Number of Genes</td><td>Number of <i>Z</i>+</td><td>Number of <i>Z</i>-</td><td>AVG (Number of <i>Z</i>+ with H3K4me3)</td><td>Number of Expected <i>Z</i>+</td><td>AVG (Number of <i>Z</i>− with H3K4me3)</td><td>Number of Expected <i>Z</i>-</td><td><i>χ</i><sup>2</sup><i>P</i>-Va... | <table><tr><td>Tissue</td><td>Number of Genes</td><td>Number of Z+</td><td>Number of Z-</td><td>AVG (Number of Z+ with H3K4me3)</td><td>Number of Expected Z+</td><td>AVG (Number of Z− with H3K4me3)</td><td>Number of Expected Z-</td><td>χ2P-Value</td></tr><tr><td>Astrocytes-cerebellar</td><td>12,418</td><td>5,923</td><t... | <table><tr><td>Cardiac myocytes</td><td>12,098</td><td>5,605</td><td>6,493</td><td>4,920.5</td><td>4,759.71</td><td>5,353</td><td>5,513.79</td><td>0.00146</td></tr></table> |
2866236e264526013aac84521d67b8df237dd77a531a8f576bdcf83c4c32d0c8.png | complex | <table><tr><td>Nuclei/field</td><td colspan="2">Central retina</td><td colspan="2">Paracentral retina</td><td colspan="2">Peripheral retina</td></tr><tr><td></td><td>Control</td><td>Scrapie</td><td>Control</td><td>Scrapie</td><td>Control</td><td>Scrapie</td></tr><tr><td>Outer nuclearlayer</td><td>5.9 ± 0.7</td><td... | <table><tr><td>Nuclei/field</td><td colspan="2">Central retina</td><td colspan="2">Paracentral retina</td><td colspan="2">Peripheral retina</td></tr></table> | <table><tr><td></td><td>Control</td><td>Scrapie</td><td>Control</td><td>Scrapie</td><td>Control</td><td>Scrapie</td></tr><tr><td>Outer nuclearlayer</td><td>5.9 ± 0.7</td><td>4.7 ± 1.1**</td><td>5.8 ± 0.6</td><td>4.9 ± 0.8*</td><td>5.3 ± 0.9</td><td>5.1 ± 1.5</td></tr><tr><td>Inner nuclearlayer</td><td>1.5 ± 0.2</td><td... |
4304e4d2671d37bc761e8488704ae7c72c539ed52181989a1d74e5c71be8c1ee.png | simple | <table><tr><td>Ref nr</td><td>Authors</td><td>Title</td><td>Journal</td><td>Year of publ</td></tr><tr><td>31</td><td>A.Ekström, A.Matthiesen, A.Widström, E.Nissen</td><td>Breastfeeding attitudes among counselling health professionals. Development of an instrument to describe breastfeeding attitudes.</td><td... | <table><tr><td>Ref nr</td><td>Authors</td><td>Title</td><td>Journal</td><td>Year of publ</td></tr><tr><td>31</td><td>A.Ekström, A.Matthiesen, A.Widström, E.Nissen</td><td>Breastfeeding attitudes among counselling health professionals. Development of an instrument to describe breastfeeding attitudes.</td><td>Scandinav... | <table><tr><td>17</td><td>S.Thorstensson, E.Nissen, A.Ekström</td><td>Professional support in pregnancy influence maternal relation to and feelings for the baby after Cesarean birth; an intervention study.</td><td>Journal of Nursing & Care 1:112.</td><td>2012</td></tr><tr><td>23</td><td>I.Blixt, L.B.Mårtensson, A.Eks... |
32dbbe20a8c9627c3bd0b1ba3b884a1ae6031d87b8522f90dabb218532bfd95f.png | complex | <table><tr><td></td><td>2003</td><td>2009</td><td>2010</td><td>2012</td><td><i>p</i>-trend</td></tr><tr><td colspan="6">Total:</td></tr><tr><td colspan="6"> PD<sup>a</sup> (95% CI)</td></tr><tr><td>Low education</td><td>23.1 (19.4–26.9)</td><td>26.9 (24.4–29.4)</td><td>28.3 (25.9–30.8)</td><td>32.2 (2... | <table><tr><td></td><td>2003</td><td>2009</td><td>2010</td><td>2012</td><td>p-trend</td></tr></table> | <table><tr><td colspan="6">Total:</td></tr><tr><td colspan="6">PDa (95% CI)</td></tr><tr><td>Low education</td><td>23.1 (19.4–26.9)</td><td>26.9 (24.4–29.4)</td><td>28.3 (25.9–30.8)</td><td>32.2 (29.0–35.5)</td><td><0.001</td></tr><tr><td>Medium education</td><td>12.5 (9.2–15.8)</td><td>12.8 (10.9–14.7)</td><td>13.7 (1... |
c05ee35aa037a119596fe6b73c15ae585f586d58a8a63f8e07bcfbed31acf0d8.png | complex | <table><tr><td>Parameter</td><td>Total (<i>n</i> = 273)<i>N</i> (%)</td><td>Recurrence (<i>n</i> = 81)</td><td>Non-recurrence (<i>n</i> = 192)</td><td><i>P</i>Re versus non-re</td></tr><tr><td>Age (years)</td><td>19.8 ± 3.5</td><td>19.4 ± 4.3</td><td>20.1 ± 4.6</td><td>0.242</td></tr><tr><td>Male, <i>n</... | <table><tr><td>Parameter</td><td>Total (n = 273)N (%)</td><td>Recurrence (n = 81)</td><td>Non-recurrence (n = 192)</td><td>PRe versus non-re</td></tr><tr><td>Age (years)</td><td>19.8 ± 3.5</td><td>19.4 ± 4.3</td><td>20.1 ± 4.6</td><td>0.242</td></tr><tr><td>Male, n (%)</td><td>221 (81.0%)</td><td>63 (28.5%)</td><td>158... | <table><tr><td>Height (cm)</td><td>173.6 ± 4.7</td><td>174.3 ± 4.1</td><td>173.0 ± 4.5</td><td>0.026</td></tr><tr><td>Weight (kg)</td><td></td><td></td><td></td><td></td></tr><tr><td>BMI (kg/m2), n (%)</td><td>59.2 ± 7.3</td><td>57.1 ± 5.0</td><td>62.2 ± 6.9</td><td><0.001</td></tr><tr><td>Underweight</td><td>75 (27.5%... |
9b4a98bebb2581f9ac322e5f2f8f595b61382cbb3aa13700ec5b7a7cd8b7deee.png | simple | <table><tr><td>Two-stage period</td><td>Possible counts</td><td>Percentages</td></tr><tr><td>Blastula-early gastrula</td><td>(0:0:0)</td><td>(0:0:0)</td></tr><tr><td>Early gastrula-mid gastrula</td><td>(4:2:0)</td><td>(67:33:0)</td></tr><tr><td>Mid gastrula-late gastrula</td><td>(5:1:0)</td><td>(83:17:0)</td></tr><tr><... | <table><tr><td>Two-stage period</td><td>Possible counts</td><td>Percentages</td></tr><tr><td>Blastula-early gastrula</td><td>(0:0:0)</td><td>(0:0:0)</td></tr><tr><td>Early gastrula-mid gastrula</td><td>(4:2:0)</td><td>(67:33:0)</td></tr><tr><td>Mid gastrula-late gastrula</td><td>(5:1:0)</td><td>(83:17:0)</td></tr></tab... | <table><tr><td>Late gastrula-early planula</td><td>(6:1:0)</td><td>(86:14:0)</td></tr><tr><td>Early planula-planula</td><td>(5:1:0)</td><td>(83:17:0)</td></tr><tr><td>Planula-late planula</td><td>(2:1:0)</td><td>(67:33:0)</td></tr></table> |
263f0e456100ee8b0286451f0fcce732f5ca91cabd32e1c3232b73db49a8b5a4.png | simple | <table><tr><td>GeneID</td><td>Protein description</td><td>Pathway</td><td>Fold change for transcripts</td><td>Fold change for proteins</td></tr><tr><td>Entcl_0332</td><td>Phosphoenolpyruvate carboxykinase (ATP) (complement(365954..367573))</td><td>Citrate cycle (TCA cycle)</td><td>2.670</td><td>3.102</td></tr><tr><td>E... | <table><tr><td>GeneID</td><td>Protein description</td><td>Pathway</td><td>Fold change for transcripts</td><td>Fold change for proteins</td></tr><tr><td>Entcl_0332</td><td>Phosphoenolpyruvate carboxykinase (ATP) (complement(365954..367573))</td><td>Citrate cycle (TCA cycle)</td><td>2.670</td><td>3.102</td></tr><tr><td>E... | <table><tr><td>GeneID</td><td>Protein description</td><td>Pathway</td><td>Fold change for transcripts</td><td>Fold change for proteins</td></tr><tr><td>tcl_0176</td><td>70))</td><td>ansporters</td><td>10</td><td></td></tr><tr><td>Entcl_3614</td><td>2-oxo-acid dehydrogenase E1 subunit, homodimeric type (complement(38770... |
18f2a6501116f5819b788f02e7d22d0e669ed06de638af2b3bd7f429600c89e8.png | complex | <table><tr><td></td><td>Original = cardio-vascular</td><td>Oncology</td><td>Psychiatric</td><td>Anti-viral</td><td>Anti-bacterial/fungal</td><td>Monogenetic orphans</td></tr><tr><td colspan="7"><i>Aspect</i></td></tr><tr><td colspan="7">Starting evidence</td></tr><tr><td>In vitro data including animal genetics</td><td>... | <table><tr><td></td><td>Original = cardio-vascular</td><td>Oncology</td><td>Psychiatric</td><td>Anti-viral</td><td>Anti-bacterial/fungal</td><td>Monogenetic orphans</td></tr><tr><td colspan="7">Aspect</td></tr><tr><td colspan="7">Starting evidence</td></tr><tr><td>In vitro data including animal genetics</td><td>2</td><... | <table><tr><td></td><td>Original = cardio-vascular</td><td>Oncology</td><td>Psychiatric</td><td>Anti-viral</td><td>Anti-bacterial/fungal</td><td>Monogenetic orphans</td></tr><tr><td>Surrogate or endpoint strategy</td><td>8</td><td>2</td><td>12</td><td>7</td><td>7</td><td>7</td></tr><tr><td colspan="7">Personalized medi... |
ddb21eeed8390e2c800c826f9066221a9ea72291ac2faeaf75a53c187ab1c55b.png | complex | <table><tr><td rowspan="3">Treatment</td><td colspan="6">Dry leaf yield (t ha<sup>−1</sup>)</td><td colspan="6">Dry stem yield (t ha<sup>−1</sup>)</td><td colspan="6">Harvest Index (HI)</td></tr><tr><td colspan="2">CSIR-IHBT</td><td colspan="2">RHRS</td><td colspan="2">PAU</td><td colspan="2">CSIR-IHBT</td>... | <table><tr><td rowspan="3">Treatment</td><td colspan="6">Dry leaf yield (t ha−1)</td><td colspan="6">Dry stem yield (t ha−1)</td><td colspan="6">Harvest Index (HI)</td></tr><tr><td colspan="2">CSIR-IHBT</td><td colspan="2">RHRS</td><td colspan="2">PAU</td><td colspan="2">CSIR-IHBT</td><td colspan="2">RHRS</td><td colsp... | <table><tr><td rowspan="3">Treatment</td><td colspan="6">Dry leaf yield (t ha−1)</td><td colspan="6">Dry stem yield (t ha−1)</td><td colspan="6">Harvest Index (HI)</td></tr><tr><td colspan="2">CSIR-IHBT</td><td colspan="2">RHRS</td><td colspan="2">PAU</td><td colspan="2">CSIR-IHBT</td><td colspan="2">RHRS</td><td colsp... |
1635a3d9d3e782c3d2c1a7f1d34c9114c6798e1d673d0480852550ab0c37cbc2.png | simple | <table><tr><td>Authors, year of publication</td><td>Samples</td><td><i>PIK3CA</i> mutations</td><td>Ref.</td></tr><tr><td>Campbell <i>et al.</i>, 2004</td><td>167 primary epithelial ovarian carcinomas, of which, 40 were samples of EnOC and OCCC and 88 were samples of serous ovarian carcinomas (all coding exons of <i>PI... | <table><tr><td>Authors, year of publication</td><td>Samples</td><td>PIK3CA mutations</td><td>Ref.</td></tr></table> | <table><tr><td>Campbell et al., 2004</td><td>167 primary epithelial ovarian carcinomas, of which, 40 were samples of EnOC and OCCC and 88 were samples of serous ovarian carcinomas (all coding exons of PIK3CA analyzed)</td><td>PIK3CA mutations in 8 (20%) of 40 EnOC and OCCC compared to only 2 (2.3%) of 88 in serous ovar... |
e4fd1e03b46eed5ccccf0d746e0420e99d7b312fbe1856bb3532948becbb12a7.png | complex | <table><tr><td></td><td colspan="2">NLR</td><td colspan="2">PLR</td><td colspan="2">RDW</td><td colspan="2">SCC-Ag</td></tr><tr><td>Stage</td><td>AUC</td><td><i>P</i> value</td><td>AUC</td><td><i>P</i> value</td><td>AUC</td><td><i>P</i> value</td><td>AUC</td><td><i>P</i> value</td></tr><tr><td>Stage I+IIA</td><td>0.515... | <table><tr><td></td><td colspan="2">NLR</td><td colspan="2">PLR</td><td colspan="2">RDW</td></tr><tr><td>Stage</td><td>AUC</td><td>P value</td><td>AUC</td><td>P value</td><td>AUC</td><td>P value</td></tr><tr><td>Stage I+IIA</td><td>0.5153</td><td>0.5112</td><td>0.5360</td><td>0.1232</td><td>0.5150</td><td>0.5205</td></... | <table><tr><td colspan="2">SCC-Ag</td></tr><tr><td>AUC</td><td>P value</td></tr><tr><td>0.8568</td><td>< 0.0001</td></tr><tr><td>0.9554</td><td>< 0.0001</td></tr><tr><td>0.9673</td><td>< 0.0001</td></tr></table> |
c1b64dce7dfa5b141033b29c04fee6ce77aa2a1077c8ddf6d4d1f4b1254918a8.png | simple | <table><tr><td>Category and Population</td><td>Core</td><td>Flexible</td><td>Odds Ratio</td><td>Significance</td></tr><tr><td>Nonsynonymous mutations in nonmutator populations</td><td>123</td><td>51</td><td>2.41</td><td><i>P</i> < 10<sup>−8</sup></td></tr><tr><td>Synonymous mutations in nonmutator populations<... | <table><tr><td>Category and Population</td><td>Core</td><td>Flexible</td><td>Odds Ratio</td></tr><tr><td>Nonsynonymous mutations in nonmutator populations</td><td>123</td><td>51</td><td>2.41</td></tr><tr><td>Synonymous mutations in nonmutator populations</td><td>10</td><td>10</td><td>1.00</td></tr><tr><td>Nonsynonymous... | <table><tr><td>Significance</td></tr><tr><td>P < 10−8</td></tr><tr><td>P = 1.0000</td></tr><tr><td>P = 0.1477</td></tr><tr><td>P = 0.4814</td></tr></table> |
addd8337e996a946b16cf4ccdcee98a9a2283b480b0440f480101977c584285c.png | complex | <table><tr><td rowspan="2">Materials</td><td>Elastic modulus</td><td>Poisson ratio</td><td>Friction coefficient</td></tr><tr><td><i>E</i> (MPa)</td><td><i>μ</i></td><td><i>f</i></td></tr><tr><td>Titanium plate</td><td>110,000</td><td>0.30</td><td>0.45</td></tr><tr><td>Titanium screw</td><td>110,000</td><td>0.30</t... | <table><tr><td rowspan="2">Materials</td><td>Elastic modulus</td><td>Poisson ratio</td><td>Friction coefficient</td></tr><tr><td>E (MPa)</td><td>μ</td><td>f</td></tr><tr><td>Titanium plate</td><td>110,000</td><td>0.30</td><td>0.45</td></tr><tr><td>Titanium screw</td><td>110,000</td><td>0.30</td><td>–</td></tr></table> | <table><tr><td rowspan="2">Materials</td><td>Elastic modulus</td><td>Poisson ratio</td><td>Friction coefficient</td></tr><tr><td>E (MPa)</td><td>μ</td><td>f</td></tr><tr><td>Articular cartilage</td><td>11.9–0.48</td><td>0.40</td><td>0.0024 ~ 0.24</td></tr><tr><td>Cortical bone</td><td>17,000</td><td>0.3</td><td>0.4</td... |
66efeb72740e307fd45e52272b77969516d3635a5d09193154ae79a88ecca778.png | simple | <table><tr><td>Name</td><td>Sequence (5’ --- 3’)</td><td>Length (bp)</td><td>Tm (° C)</td></tr><tr><td><i>flp-14</i> RT F</td><td>GCGAGTCCATGTGTAGCAGCTAAT</td><td>117</td><td>60</td></tr><tr><td><i>flp-14</i> RT R</td><td>GGGAGATGAAGAACGTTTACTACTTTGCC</td><td></td><td></td></tr><tr><td><i>flp-18</i> RT... | <table><tr><td>Name</td><td>Sequence (5’ --- 3’)</td><td>Length (bp)</td><td>Tm (° C)</td></tr><tr><td>flp-14 RT F</td><td>GCGAGTCCATGTGTAGCAGCTAAT</td><td>117</td><td>60</td></tr><tr><td>flp-14 RT R</td><td>GGGAGATGAAGAACGTTTACTACTTTGCC</td><td></td><td></td></tr><tr><td>flp-18 RT F</td><td>AGGATGACTTATTGCGCCAGGA</td>... | <table><tr><td>Name</td><td>Sequence (5’ --- 3’)</td><td>Length (bp)</td><td>Tm (° C)</td></tr><tr><td>18SrRNA Tobacco RT F</td><td>CGCGCGCTACACTGATGTATTCAA</td><td>172</td><td>60</td></tr><tr><td>18SrRNA Tobacco RT R</td><td>TACAAAGGGCAGGGACGTAGTCAA</td><td></td><td></td></tr><tr><td>18SrRNAM.incognita RT F</td><td>TC... |
6848e808044ea655c4e099fbb9f16cc2ce08574234fa4610b69334181622ff15.png | simple | <table><tr><td>Strain</td><td></td><td>Animal No.</td><td>Incidence (%)</td><td>Multiplicity <sup>a)</sup></td></tr><tr><td>FVB/N</td><td>total</td><td>16</td><td>16 (100)</td><td>32.56 ± 3.60</td></tr><tr><td></td><td> female</td><td>9</td><td>9 (100)</td><td>28.22 ± 4.46</td></tr><tr><td></td><td> male</td>... | <table><tr><td>Strain</td><td></td><td>Animal No.</td><td>Incidence (%)</td><td>Multiplicity a)</td></tr><tr><td>FVB/N</td><td>total</td><td>16</td><td>16 (100)</td><td>32.56 ± 3.60</td></tr><tr><td></td><td>female</td><td>9</td><td>9 (100)</td><td>28.22 ± 4.46</td></tr><tr><td></td><td>male</td><td>7</td><td>7 (100)</... | <table><tr><td>Strain</td><td></td><td>Animal No.</td><td>Incidence (%)</td><td>Multiplicity a)</td></tr><tr><td></td><td>female</td><td>8</td><td>0 (0)</td><td>0</td></tr><tr><td></td><td>male</td><td>9</td><td>0 (0)</td><td>0</td></tr><tr><td>(FxP) × F</td><td>total</td><td>208</td><td>123(56.7)</td><td>4.86 ± 0.56</... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.